| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | beta-2-microglobulin binding | 2.01e-09 | 12 | 232 | 6 | GO:0030881 | |
| GeneOntologyMolecularFunction | natural killer cell lectin-like receptor binding | 2.56e-08 | 17 | 232 | 6 | GO:0046703 | |
| GeneOntologyMolecularFunction | peptide antigen binding | 1.48e-06 | 49 | 232 | 7 | GO:0042605 | |
| GeneOntologyMolecularFunction | CD8 receptor binding | 2.14e-06 | 9 | 232 | 4 | GO:0042610 | |
| GeneOntologyMolecularFunction | TAP complex binding | 2.14e-06 | 9 | 232 | 4 | GO:0062061 | |
| GeneOntologyMolecularFunction | TAP1 binding | 3.53e-06 | 10 | 232 | 4 | GO:0046978 | |
| GeneOntologyMolecularFunction | TAP2 binding | 3.53e-06 | 10 | 232 | 4 | GO:0046979 | |
| GeneOntologyMolecularFunction | TAP binding | 3.53e-06 | 10 | 232 | 4 | GO:0046977 | |
| GeneOntologyMolecularFunction | T cell receptor binding | 7.43e-05 | 20 | 232 | 4 | GO:0042608 | |
| GeneOntologyMolecularFunction | antigen binding | HFE HLA-A HLA-B HLA-C HLA-H IGHV1-69D MICB MICA IGHV1-69 IGHV1-18 | 7.93e-05 | 190 | 232 | 10 | GO:0003823 |
| GeneOntologyMolecularFunction | 14-3-3 protein binding | 1.21e-04 | 42 | 232 | 5 | GO:0071889 | |
| GeneOntologyMolecularFunction | protein-glutamine gamma-glutamyltransferase activity | 1.24e-04 | 9 | 232 | 3 | GO:0003810 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity | 1.89e-04 | 46 | 232 | 5 | GO:0005245 | |
| GeneOntologyMolecularFunction | guanyl-nucleotide exchange factor activity | OBSCN ANKRD27 ARHGEF7 VAV3 ARHGEF37 MCF2L VAV2 ARHGEF6 RIC1 MON1A | 3.87e-04 | 231 | 232 | 10 | GO:0005085 |
| GeneOntologyMolecularFunction | MHC class I protein binding | 4.95e-04 | 32 | 232 | 4 | GO:0042288 | |
| GeneOntologyMolecularFunction | adenylate cyclase inhibitor activity | 7.94e-04 | 4 | 232 | 2 | GO:0010855 | |
| GeneOntologyMolecularFunction | lactoperoxidase activity | 7.94e-04 | 4 | 232 | 2 | GO:0140825 | |
| GeneOntologyMolecularFunction | anandamide 8,9 epoxidase activity | 7.94e-04 | 4 | 232 | 2 | GO:0062187 | |
| GeneOntologyMolecularFunction | anandamide 11,12 epoxidase activity | 7.94e-04 | 4 | 232 | 2 | GO:0062188 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein tyrosine phosphatase activity | 9.33e-04 | 17 | 232 | 3 | GO:0005001 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein phosphatase activity | 9.33e-04 | 17 | 232 | 3 | GO:0019198 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein tyrosine kinase activity | 9.50e-04 | 65 | 232 | 5 | GO:0004714 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 1.11e-03 | 18 | 232 | 3 | GO:0008569 | |
| GeneOntologyMolecularFunction | peptide binding | HFE HLA-A HLA-B HLA-C HLA-H ITGAM MICB MICA CLSTN1 MEMO1 CST2 | 1.29e-03 | 318 | 232 | 11 | GO:0042277 |
| GeneOntologyMolecularFunction | cyclase inhibitor activity | 1.31e-03 | 5 | 232 | 2 | GO:0010852 | |
| GeneOntologyMolecularFunction | gated channel activity | GABRB2 CHRNA1 RYR1 CHRNE CLCA1 SCNN1D CACNA1H CLCA4 TPCN2 GRM7 CACNG7 | 1.90e-03 | 334 | 232 | 11 | GO:0022836 |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | 1.93e-03 | 193 | 232 | 8 | GO:0015276 | |
| GeneOntologyMolecularFunction | anandamide 14,15 epoxidase activity | 1.96e-03 | 6 | 232 | 2 | GO:0062189 | |
| GeneOntologyMolecularFunction | anandamide epoxidase activity | 1.96e-03 | 6 | 232 | 2 | GO:0062186 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent | 1.87e-10 | 16 | 227 | 7 | GO:0002486 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway | 3.16e-10 | 17 | 227 | 7 | GO:0002484 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class Ib | 3.16e-10 | 17 | 227 | 7 | GO:0002476 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of peptide antigen via MHC class Ib | 5.12e-10 | 18 | 227 | 7 | GO:0002428 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class I | 3.76e-09 | 23 | 227 | 7 | GO:0019885 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen | 7.24e-09 | 25 | 227 | 7 | GO:0002483 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation via MHC class Ib | 7.24e-09 | 25 | 227 | 7 | GO:0002475 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous antigen | 4.75e-08 | 32 | 227 | 7 | GO:0019883 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of peptide antigen via MHC class I | 2.92e-07 | 41 | 227 | 7 | GO:0002474 | |
| GeneOntologyBiologicalProcess | positive regulation of T cell mediated cytotoxicity | 3.47e-07 | 42 | 227 | 7 | GO:0001916 | |
| GeneOntologyBiologicalProcess | positive regulation of cell killing | 5.43e-07 | 88 | 227 | 9 | GO:0031343 | |
| GeneOntologyBiologicalProcess | regulation of cell killing | 7.18e-07 | 147 | 227 | 11 | GO:0031341 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent | 9.66e-07 | 8 | 227 | 4 | GO:0002485 | |
| GeneOntologyBiologicalProcess | T cell mediated cytotoxicity | 9.99e-07 | 70 | 227 | 8 | GO:0001913 | |
| GeneOntologyBiologicalProcess | regulation of T cell mediated cytotoxicity | 1.79e-06 | 53 | 227 | 7 | GO:0001914 | |
| GeneOntologyBiologicalProcess | positive regulation of leukocyte mediated cytotoxicity | 2.54e-06 | 79 | 227 | 8 | GO:0001912 | |
| GeneOntologyBiologicalProcess | regulation of leukocyte mediated cytotoxicity | 9.58e-06 | 124 | 227 | 9 | GO:0001910 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | CDHR2 ITGAM CD84 PTPRD IGSF9 SDK1 MPZ PCDHAC1 ESAM CLSTN1 LGALS9 CELSR3 TENM1 CDH13 | 1.04e-05 | 313 | 227 | 14 | GO:0098742 |
| GeneOntologyBiologicalProcess | positive regulation of T cell mediated immunity | 1.72e-05 | 74 | 227 | 7 | GO:0002711 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of peptide antigen | 2.05e-05 | 76 | 227 | 7 | GO:0048002 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of exogenous peptide antigen via MHC class I | 3.87e-05 | 18 | 227 | 4 | GO:0042590 | |
| GeneOntologyBiologicalProcess | leukocyte mediated cytotoxicity | 4.42e-05 | 187 | 227 | 10 | GO:0001909 | |
| GeneOntologyBiologicalProcess | adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | CFH HFE HLA-A HLA-B HLA-C BACH2 HLA-H IGHV1-69D MICB MICA IGHV1-69 IGHV1-18 CR2 LGALS9 CSF3R PRF1 | 5.69e-05 | 462 | 227 | 16 | GO:0002460 |
| GeneOntologyBiologicalProcess | cell junction organization | GABRB2 RELN HAPLN4 ITGAM CHRNA1 NRP1 RHPN1 PTPRD PTPRK ARHGEF7 IGSF9 SDK1 MPZ SORBS2 SEMA7A DSP PCLO UBE3B ESAM DGKZ SORBS1 CLSTN1 LRP4 CDH13 EPHA7 | 7.62e-05 | 974 | 227 | 25 | GO:0034330 |
| GeneOntologyBiologicalProcess | T cell mediated immunity | 8.34e-05 | 163 | 227 | 9 | GO:0002456 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte mediated immunity | 9.26e-05 | 96 | 227 | 7 | GO:0002704 | |
| GeneOntologyBiologicalProcess | negative regulation of neuron projection development | 1.10e-04 | 169 | 227 | 9 | GO:0010977 | |
| GeneOntologyBiologicalProcess | lymphocyte mediated immunity | CFH HFE HLA-A HLA-B HLA-C HLA-H IGHV1-69D MICB MICA IGHV1-69 IGHV1-18 CR2 LGALS9 CSF3R PRF1 | 1.44e-04 | 449 | 227 | 15 | GO:0002449 |
| GeneOntologyBiologicalProcess | cell junction assembly | GABRB2 RELN HAPLN4 NRP1 RHPN1 PTPRD PTPRK ARHGEF7 SDK1 PCLO UBE3B ESAM SORBS1 CLSTN1 LRP4 CDH13 EPHA7 | 2.00e-04 | 569 | 227 | 17 | GO:0034329 |
| GeneOntologyBiologicalProcess | peptide cross-linking | 2.06e-04 | 27 | 227 | 4 | GO:0018149 | |
| GeneOntologyBiologicalProcess | immune effector process | CFH HFE HLA-A HLA-B HLA-C HLA-H EPX ITGAM PGC IGHV1-69D CD84 MICB MICA VAV3 VAV2 SEMA7A IGHV1-69 IGHV1-18 CR2 LGALS9 CSF3R PRF1 | 2.16e-04 | 859 | 227 | 22 | GO:0002252 |
| GeneOntologyBiologicalProcess | synapse organization | GABRB2 RELN HAPLN4 ITGAM CHRNA1 NRP1 PTPRD ARHGEF7 IGSF9 SDK1 SORBS2 SEMA7A PCLO UBE3B DGKZ SORBS1 CLSTN1 LRP4 EPHA7 | 2.19e-04 | 685 | 227 | 19 | GO:0050808 |
| GeneOntologyBiologicalProcess | regulation of T cell mediated immunity | 2.30e-04 | 111 | 227 | 7 | GO:0002709 | |
| GeneOntologyBiologicalProcess | leukocyte mediated immunity | CFH HFE HLA-A HLA-B HLA-C HLA-H ITGAM IGHV1-69D CD84 MICB MICA IGHV1-69 IGHV1-18 CR2 LGALS9 CSF3R PRF1 | 2.31e-04 | 576 | 227 | 17 | GO:0002443 |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | 2.36e-04 | 187 | 227 | 9 | GO:0007156 | |
| GeneOntologyBiologicalProcess | regulation of receptor clustering | 2.73e-04 | 29 | 227 | 4 | GO:1903909 | |
| GeneOntologyBiologicalProcess | receptor clustering | 3.10e-04 | 83 | 227 | 6 | GO:0043113 | |
| GeneOntologyBiologicalProcess | negative regulation of lymphocyte mediated immunity | 3.10e-04 | 83 | 227 | 6 | GO:0002707 | |
| GeneOntologyBiologicalProcess | negative regulation of hydrogen peroxide-mediated programmed cell death | 3.47e-04 | 13 | 227 | 3 | GO:1901299 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion | CFH HFE HLA-A CDHR2 ADGRV1 DCC ITGA7 ITGAM CD84 PTPRD IGSF9 SDK1 MPZ DSP MAP3K8 AKNA PCDHAC1 ESAM PTPRU CLSTN1 LGALS9 CELSR3 TENM1 CDH13 EPHA7 | 3.56e-04 | 1077 | 227 | 25 | GO:0098609 |
| GeneOntologyBiologicalProcess | regulation of immune effector process | CFH HFE HLA-A HLA-B HLA-C HLA-H EPX ITGAM PGC CD84 MICB MICA SEMA7A CR2 LGALS9 | 4.26e-04 | 497 | 227 | 15 | GO:0002697 |
| GeneOntologyBiologicalProcess | regulation of plasma membrane bounded cell projection organization | HGF RELN HLA-A HLA-B HLA-C CDHR2 ENTR1 HLA-H FNBP1L DCC ANKRD27 NRP1 PTPRD ARHGEF7 MINAR1 KIF13B SEMA7A DDR2 TENM1 LRP4 EPHA7 | 4.54e-04 | 846 | 227 | 21 | GO:0120035 |
| GeneOntologyBiologicalProcess | negative regulation of immune effector process | 5.17e-04 | 166 | 227 | 8 | GO:0002698 | |
| GeneOntologyBiologicalProcess | motor neuron migration | 5.43e-04 | 15 | 227 | 3 | GO:0097475 | |
| GeneOntologyBiologicalProcess | regulation of skeletal muscle acetylcholine-gated channel clustering | 5.43e-04 | 15 | 227 | 3 | GO:1904393 | |
| GeneOntologyBiologicalProcess | regulation of cell projection organization | HGF RELN HLA-A HLA-B HLA-C CDHR2 ENTR1 HLA-H FNBP1L DCC ANKRD27 NRP1 PTPRD ARHGEF7 MINAR1 KIF13B SEMA7A DDR2 TENM1 LRP4 EPHA7 | 5.88e-04 | 863 | 227 | 21 | GO:0031344 |
| GeneOntologyCellularComponent | MHC class I protein complex | 3.88e-08 | 10 | 232 | 5 | GO:0042612 | |
| GeneOntologyCellularComponent | MHC class Ib protein complex | 5.04e-07 | 7 | 232 | 4 | GO:0032398 | |
| GeneOntologyCellularComponent | cell surface | CFH HFE HLA-A HLA-B HLA-C HLA-H ADGRV1 DCC ITGA7 ITGAM CHRNA1 NRP1 CD84 PTPRK MICB TMPRSS11D MICA FGFR3 SEMA7A LCT CLSTN1 CR2 GRM7 SLC6A2 PLA2R1 IGF2R CSF3R ENTPD2 LRP4 DCBLD2 CDH13 | 2.19e-06 | 1111 | 232 | 31 | GO:0009986 |
| GeneOntologyCellularComponent | receptor complex | GABRB2 HFE ADGRV1 ITGA7 ITGAM LRP1B CHRNA1 CHRNE NRP1 LOXL4 FGFR3 IMPG2 DDR2 ITLN2 CR2 GRM7 PLA2R1 CACNG7 CSF3R TRAV27 | 8.27e-06 | 581 | 232 | 20 | GO:0043235 |
| GeneOntologyCellularComponent | MHC protein complex | 8.77e-06 | 26 | 232 | 5 | GO:0042611 | |
| GeneOntologyCellularComponent | MHC class I peptide loading complex | 1.36e-05 | 14 | 232 | 4 | GO:0042824 | |
| GeneOntologyCellularComponent | cis-Golgi network membrane | 3.14e-05 | 17 | 232 | 4 | GO:0033106 | |
| GeneOntologyCellularComponent | GABA-ergic synapse | 9.34e-05 | 164 | 232 | 9 | GO:0098982 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | RELN HAPLN4 AEBP1 LOXL4 ADAMTSL4 IMPG2 COL12A1 SEMA7A MMP28 RBP3 ITLN2 HAPLN1 LGALS9 TGM3 ENTPD2 CST2 CDH13 | 9.53e-05 | 530 | 232 | 17 | GO:0062023 |
| GeneOntologyCellularComponent | endoplasmic reticulum exit site | 9.82e-05 | 42 | 232 | 5 | GO:0070971 | |
| GeneOntologyCellularComponent | Golgi medial cisterna | 1.11e-04 | 23 | 232 | 4 | GO:0005797 | |
| GeneOntologyCellularComponent | side of membrane | CFH HFE HLA-A HLA-B HLA-C HLA-H ITGA7 ITGAM RYR1 CD84 MICB MICA FGFR3 MCF2L SEMA7A ITLN2 LCT CR2 EEF1A1 TGM3 CSF3R FRMD6 CDH13 | 1.20e-04 | 875 | 232 | 23 | GO:0098552 |
| GeneOntologyCellularComponent | inner dynein arm | 1.53e-04 | 10 | 232 | 3 | GO:0036156 | |
| GeneOntologyCellularComponent | axonemal dynein complex | 1.56e-04 | 25 | 232 | 4 | GO:0005858 | |
| GeneOntologyCellularComponent | external side of plasma membrane | CFH HFE HLA-A HLA-B HLA-C HLA-H ITGA7 ITGAM CD84 MICB MICA SEMA7A LCT CR2 CSF3R CDH13 | 2.39e-04 | 519 | 232 | 16 | GO:0009897 |
| GeneOntologyCellularComponent | microtubule associated complex | 4.47e-04 | 161 | 232 | 8 | GO:0005875 | |
| GeneOntologyCellularComponent | endoplasmic reticulum protein-containing complex | 4.98e-04 | 125 | 232 | 7 | GO:0140534 | |
| GeneOntologyCellularComponent | anchoring junction | CDHR2 OBSCN ITGA7 NRP1 PTPRK ARHGEF7 CPNE3 FGFR3 BAIAP2L2 ARHGEF6 SORBS2 DSP DDR2 ESAM SORBS1 PTPRU GSN TGM1 MISP IGF2R FRMD6 SH3PXD2A CDH13 | 5.68e-04 | 976 | 232 | 23 | GO:0070161 |
| GeneOntologyCellularComponent | lumenal side of endoplasmic reticulum membrane | 5.91e-04 | 35 | 232 | 4 | GO:0098553 | |
| GeneOntologyCellularComponent | postsynaptic membrane | GABRB2 DCC CHRNA1 CHRNE NRP1 CACNA1H DRD4 CLSTN1 GRM7 SLC6A6 CACNG7 CELSR3 EPHA7 | 6.30e-04 | 405 | 232 | 13 | GO:0045211 |
| GeneOntologyCellularComponent | ER to Golgi transport vesicle membrane | 7.22e-04 | 64 | 232 | 5 | GO:0012507 | |
| GeneOntologyCellularComponent | synaptic membrane | GABRB2 DCC CHRNA1 CHRNE NRP1 PTPRD CACNA1H DRD4 CLSTN1 GRM7 SLC6A2 SLC6A6 CACNG7 CELSR3 LRP4 EPHA7 | 8.45e-04 | 583 | 232 | 16 | GO:0097060 |
| GeneOntologyCellularComponent | extracellular matrix | RELN HAPLN4 AEBP1 LOXL4 ADAMTSL4 IMPG2 COL12A1 SEMA7A MMP28 RBP3 ITLN2 HAPLN1 LGALS9 TGM3 ENTPD2 CST2 CDH13 | 1.10e-03 | 656 | 232 | 17 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | RELN HAPLN4 AEBP1 LOXL4 ADAMTSL4 IMPG2 COL12A1 SEMA7A MMP28 RBP3 ITLN2 HAPLN1 LGALS9 TGM3 ENTPD2 CST2 CDH13 | 1.13e-03 | 658 | 232 | 17 | GO:0030312 |
| GeneOntologyCellularComponent | neuromuscular junction | 1.58e-03 | 112 | 232 | 6 | GO:0031594 | |
| GeneOntologyCellularComponent | cell body | CFH PCSK2 RELN CCT3 NRP1 PTPRK ARHGEF7 CACNA1H BEGAIN SORBS2 DRD4 PCLO GRM7 SLC6A2 SLC6A6 CACNG7 ENTPD2 CST2 LRP4 PINK1 EPHA7 | 1.65e-03 | 929 | 232 | 21 | GO:0044297 |
| GeneOntologyCellularComponent | interphotoreceptor matrix | 1.79e-03 | 6 | 232 | 2 | GO:0033165 | |
| GeneOntologyCellularComponent | postsynaptic specialization membrane | 1.88e-03 | 201 | 232 | 8 | GO:0099634 | |
| GeneOntologyCellularComponent | lumenal side of membrane | 1.96e-03 | 48 | 232 | 4 | GO:0098576 | |
| GeneOntologyCellularComponent | membrane raft | HLA-A HLA-B HLA-C HLA-H ITGAM CACNA1H SMURF2 SORBS1 ITLN2 LRP4 CDH13 | 2.50e-03 | 362 | 232 | 11 | GO:0045121 |
| GeneOntologyCellularComponent | membrane microdomain | HLA-A HLA-B HLA-C HLA-H ITGAM CACNA1H SMURF2 SORBS1 ITLN2 LRP4 CDH13 | 2.60e-03 | 364 | 232 | 11 | GO:0098857 |
| GeneOntologyCellularComponent | cell cortex | HFE FNBP1L RYR1 ARHGEF7 DRD4 PCLO GRM7 GSN EEF1A1 ACTR1A MISP | 3.01e-03 | 371 | 232 | 11 | GO:0005938 |
| GeneOntologyCellularComponent | dynein complex | 3.03e-03 | 54 | 232 | 4 | GO:0030286 | |
| GeneOntologyCellularComponent | dynactin complex | 3.29e-03 | 8 | 232 | 2 | GO:0005869 | |
| HumanPheno | Abnormality of jaw muscles | 9.53e-06 | 31 | 85 | 6 | HP:0045037 | |
| HumanPheno | Abnormal spirometry test | HFE HLA-B CHRNA1 CHRNE FGFR3 DNAH9 CLCA4 DSP DDR2 CR2 RTL1 LRP4 | 2.73e-05 | 175 | 85 | 12 | HP:0032340 |
| MousePheno | spinal cord inflammation | 2.27e-06 | 8 | 191 | 4 | MP:0030987 | |
| MousePheno | decreased muscle weight | 5.88e-06 | 34 | 191 | 6 | MP:0004232 | |
| MousePheno | demyelination | 2.06e-05 | 85 | 191 | 8 | MP:0000921 | |
| MousePheno | abnormal muscle weight | 2.76e-05 | 44 | 191 | 6 | MP:0004233 | |
| MousePheno | decreased immature NK cell number | 3.04e-05 | 14 | 191 | 4 | MP:0013666 | |
| MousePheno | abnormal cranial cartilage morphology | 5.80e-05 | 50 | 191 | 6 | MP:0030464 | |
| MousePheno | decreased mature NK cell number | 8.89e-05 | 18 | 191 | 4 | MP:0013672 | |
| MousePheno | abnormal immature NK cell number | 1.11e-04 | 19 | 191 | 4 | MP:0013665 | |
| MousePheno | abnormal immature NK cell morphology | 1.11e-04 | 19 | 191 | 4 | MP:0013699 | |
| Domain | - | HFE HLA-A HLA-B HLA-C OBSCN HAPLN4 TGM6 DCC CD84 FNDC7 IL22RA2 PTPRD PTPRK MICB IGSF9 MICA FGFR3 SDK1 SECTM1 MPZ COL12A1 SEMA7A FNDC4 ESAM PTPRU HAPLN1 TGM1 TGM3 CSF3R EPHA7 | 6.30e-10 | 663 | 228 | 30 | 2.60.40.10 |
| Domain | Ig-like_fold | HFE HLA-A HLA-B HLA-C OBSCN HLA-H HAPLN4 TGM6 DCC CD84 FNDC7 IL22RA2 PTPRD PTPRK MICB IGSF9 MICA FGFR3 SDK1 SECTM1 MPZ COL12A1 SEMA7A FNDC4 ESAM PTPRU HAPLN1 TGM1 TGM3 CSF3R EPHA7 | 6.58e-10 | 706 | 228 | 31 | IPR013783 |
| Domain | MHC_I | 3.70e-09 | 21 | 228 | 7 | PF00129 | |
| Domain | MHC_I_a_a1/a2 | 3.70e-09 | 21 | 228 | 7 | IPR001039 | |
| Domain | Ig-like_dom | HFE HLA-A HLA-B HLA-C OBSCN HLA-H HAPLN4 DCC CD84 PTPRD PTPRK MICB IGSF9 MICA FGFR3 SDK1 MPZ SEMA7A ESAM PTPRU HAPLN1 CSF3R | 2.54e-07 | 503 | 228 | 22 | IPR007110 |
| Domain | FN3_dom | KIAA0319L OBSCN DCC FNDC7 IL22RA2 PTPRD PTPRK IGSF9 SDK1 COL12A1 FNDC4 PTPRU CSF3R EPHA7 | 2.99e-07 | 209 | 228 | 14 | IPR003961 |
| Domain | MHC_I_a_C | 3.18e-07 | 6 | 228 | 4 | IPR010579 | |
| Domain | MHC_I_C | 3.18e-07 | 6 | 228 | 4 | PF06623 | |
| Domain | - | 3.47e-07 | 24 | 228 | 6 | 3.30.500.10 | |
| Domain | MHC_I-like_Ag-recog | 3.47e-07 | 24 | 228 | 6 | IPR011161 | |
| Domain | FN3 | KIAA0319L OBSCN DCC FNDC7 PTPRD PTPRK IGSF9 SDK1 COL12A1 FNDC4 PTPRU CSF3R EPHA7 | 4.63e-07 | 185 | 228 | 13 | SM00060 |
| Domain | IG_LIKE | HFE HLA-A HLA-B HLA-C OBSCN HLA-H HAPLN4 DCC CD84 PTPRD PTPRK MICB IGSF9 MICA FGFR3 SDK1 MPZ SEMA7A ESAM PTPRU HAPLN1 | 6.94e-07 | 491 | 228 | 21 | PS50835 |
| Domain | fn3 | OBSCN DCC FNDC7 PTPRD PTPRK IGSF9 SDK1 COL12A1 FNDC4 PTPRU CSF3R EPHA7 | 7.36e-07 | 162 | 228 | 12 | PF00041 |
| Domain | SH3_2 | ARHGEF7 VAV3 ARHGEF37 MCF2L BAIAP2L2 VAV2 ARHGEF6 SORBS2 SORBS1 | 1.05e-06 | 86 | 228 | 9 | PF07653 |
| Domain | SH3_2 | ARHGEF7 VAV3 ARHGEF37 MCF2L BAIAP2L2 VAV2 ARHGEF6 SORBS2 SORBS1 | 1.05e-06 | 86 | 228 | 9 | IPR011511 |
| Domain | FN3 | OBSCN DCC FNDC7 IL22RA2 PTPRD PTPRK IGSF9 SDK1 COL12A1 FNDC4 PTPRU CSF3R EPHA7 | 1.06e-06 | 199 | 228 | 13 | PS50853 |
| Domain | Galactose-bd-like | 2.22e-06 | 94 | 228 | 9 | IPR008979 | |
| Domain | C1-set | 4.01e-06 | 54 | 228 | 7 | PF07654 | |
| Domain | IGc1 | 5.14e-06 | 56 | 228 | 7 | SM00407 | |
| Domain | MHC_I/II-like_Ag-recog | 6.17e-06 | 38 | 228 | 6 | IPR011162 | |
| Domain | Ig_C1-set | 6.53e-06 | 58 | 228 | 7 | IPR003597 | |
| Domain | GDS_CDC24_CS | 7.22e-06 | 39 | 228 | 6 | IPR001331 | |
| Domain | DH_1 | 1.14e-05 | 63 | 228 | 7 | PS00741 | |
| Domain | SH3 | OBSCN FNBP1L ARHGEF7 VAV3 ARHGEF37 MCF2L BAIAP2L2 VAV2 ARHGEF6 SORBS2 SORBS1 SH3PXD2A | 1.45e-05 | 216 | 228 | 12 | SM00326 |
| Domain | SH3 | OBSCN FNBP1L ARHGEF7 VAV3 ARHGEF37 MCF2L BAIAP2L2 VAV2 ARHGEF6 SORBS2 SORBS1 SH3PXD2A | 1.45e-05 | 216 | 228 | 12 | PS50002 |
| Domain | SH3_domain | OBSCN FNBP1L ARHGEF7 VAV3 ARHGEF37 MCF2L BAIAP2L2 VAV2 ARHGEF6 SORBS2 SORBS1 SH3PXD2A | 1.74e-05 | 220 | 228 | 12 | IPR001452 |
| Domain | RhoGEF | 1.90e-05 | 68 | 228 | 7 | SM00325 | |
| Domain | RhoGEF | 2.30e-05 | 70 | 228 | 7 | PF00621 | |
| Domain | DH_2 | 2.30e-05 | 70 | 228 | 7 | PS50010 | |
| Domain | - | 2.52e-05 | 71 | 228 | 7 | 1.20.900.10 | |
| Domain | DH-domain | 2.52e-05 | 71 | 228 | 7 | IPR000219 | |
| Domain | - | 3.03e-05 | 73 | 228 | 7 | 2.60.120.260 | |
| Domain | ConA-like_dom | ADGRV1 RYR1 NRP1 PTPRK COL12A1 SHBG PTPRU CLSTN1 TRIM7 LGALS9 CELSR3 | 8.25e-05 | 219 | 228 | 11 | IPR013320 |
| Domain | FA58C | 1.10e-04 | 21 | 228 | 4 | SM00231 | |
| Domain | FA58C_3 | 1.10e-04 | 21 | 228 | 4 | PS50022 | |
| Domain | FA58C_1 | 1.10e-04 | 21 | 228 | 4 | PS01285 | |
| Domain | FA58C_2 | 1.10e-04 | 21 | 228 | 4 | PS01286 | |
| Domain | CH | 1.40e-04 | 65 | 228 | 6 | SM00033 | |
| Domain | Transglut_N | 1.43e-04 | 9 | 228 | 3 | PF00868 | |
| Domain | TRANSGLUTAMINASES | 1.43e-04 | 9 | 228 | 3 | PS00547 | |
| Domain | - | 1.43e-04 | 9 | 228 | 3 | 3.90.260.10 | |
| Domain | Gln_gamma-glutamylTfrase_euk | 1.43e-04 | 9 | 228 | 3 | IPR023608 | |
| Domain | Transglutaminase_AS | 1.43e-04 | 9 | 228 | 3 | IPR013808 | |
| Domain | Transglutaminase_N | 1.43e-04 | 9 | 228 | 3 | IPR001102 | |
| Domain | Transglut_C | 1.43e-04 | 9 | 228 | 3 | PF00927 | |
| Domain | Arp1 | 1.48e-04 | 2 | 228 | 2 | IPR029909 | |
| Domain | SH3_1 | FNBP1L ARHGEF7 VAV3 ARHGEF37 VAV2 ARHGEF6 SORBS2 SORBS1 SH3PXD2A | 1.89e-04 | 164 | 228 | 9 | PF00018 |
| Domain | F5_F8_type_C | 1.90e-04 | 24 | 228 | 4 | PF00754 | |
| Domain | FA58C | 1.90e-04 | 24 | 228 | 4 | IPR000421 | |
| Domain | Transglutaminase_C | 2.02e-04 | 10 | 228 | 3 | IPR008958 | |
| Domain | CH | 2.12e-04 | 70 | 228 | 6 | PF00307 | |
| Domain | - | 2.29e-04 | 71 | 228 | 6 | 1.10.418.10 | |
| Domain | CH | 2.67e-04 | 73 | 228 | 6 | PS50021 | |
| Domain | Transglutaminase-like | 2.76e-04 | 11 | 228 | 3 | IPR002931 | |
| Domain | TGc | 2.76e-04 | 11 | 228 | 3 | SM00460 | |
| Domain | Transglut_core | 2.76e-04 | 11 | 228 | 3 | PF01841 | |
| Domain | CH-domain | 3.09e-04 | 75 | 228 | 6 | IPR001715 | |
| Domain | EGF-like_CS | CLEC18A RELN LRP1B ATRAID IMPG2 CLEC18C CELSR3 PRF1 TENM1 LRP4 EPHA7 | 3.79e-04 | 261 | 228 | 11 | IPR013032 |
| Domain | EGF_2 | CLEC18A RELN LRP1B ATRAID IMPG2 CLEC18C CELSR3 PRF1 TENM1 LRP4 EPHA7 | 4.31e-04 | 265 | 228 | 11 | PS01186 |
| Domain | CLCA_chordata | 4.42e-04 | 3 | 228 | 2 | IPR004727 | |
| Domain | SOHO | 4.42e-04 | 3 | 228 | 2 | PS50831 | |
| Domain | CLCA | 4.42e-04 | 3 | 228 | 2 | IPR013642 | |
| Domain | Vav | 4.42e-04 | 3 | 228 | 2 | IPR028530 | |
| Domain | Sorb | 4.42e-04 | 3 | 228 | 2 | SM00459 | |
| Domain | CLCA | 4.42e-04 | 3 | 228 | 2 | PF08434 | |
| Domain | Sorb | 4.42e-04 | 3 | 228 | 2 | PF02208 | |
| Domain | SoHo_dom | 4.42e-04 | 3 | 228 | 2 | IPR003127 | |
| Domain | Dynein_heavy_chain_D4_dom | 5.92e-04 | 14 | 228 | 3 | IPR024317 | |
| Domain | Dynein_heavy_dom-2 | 5.92e-04 | 14 | 228 | 3 | IPR013602 | |
| Domain | DHC_N2 | 5.92e-04 | 14 | 228 | 3 | PF08393 | |
| Domain | ATPase_dyneun-rel_AAA | 5.92e-04 | 14 | 228 | 3 | IPR011704 | |
| Domain | AAA_8 | 5.92e-04 | 14 | 228 | 3 | PF12780 | |
| Domain | AAA_5 | 5.92e-04 | 14 | 228 | 3 | PF07728 | |
| Domain | EGF_3 | CLEC18A RELN LRP1B ATRAID IMPG2 CLEC18C CELSR3 PRF1 TENM1 LRP4 | 6.46e-04 | 235 | 228 | 10 | PS50026 |
| Domain | IG | OBSCN HAPLN4 DCC CD84 PTPRD PTPRK IGSF9 FGFR3 SDK1 MPZ SEMA7A ESAM PTPRU HAPLN1 | 6.99e-04 | 421 | 228 | 14 | SM00409 |
| Domain | Ig_sub | OBSCN HAPLN4 DCC CD84 PTPRD PTPRK IGSF9 FGFR3 SDK1 MPZ SEMA7A ESAM PTPRU HAPLN1 | 6.99e-04 | 421 | 228 | 14 | IPR003599 |
| Domain | Ig/MHC_CS | 7.02e-04 | 58 | 228 | 5 | IPR003006 | |
| Domain | DHC_fam | 7.33e-04 | 15 | 228 | 3 | IPR026983 | |
| Domain | Beta/gamma_crystallin | 7.33e-04 | 15 | 228 | 3 | IPR001064 | |
| Domain | Dynein_heavy | 7.33e-04 | 15 | 228 | 3 | PF03028 | |
| Domain | CRYSTALLIN_BETA_GAMMA | 7.33e-04 | 15 | 228 | 3 | PS50915 | |
| Domain | Dynein_heavy_dom | 7.33e-04 | 15 | 228 | 3 | IPR004273 | |
| Domain | Crystall | 7.33e-04 | 15 | 228 | 3 | PF00030 | |
| Domain | XTALbg | 7.33e-04 | 15 | 228 | 3 | SM00247 | |
| Domain | IG_MHC | 8.21e-04 | 60 | 228 | 5 | PS00290 | |
| Domain | MAM_1 | 8.94e-04 | 16 | 228 | 3 | PS00740 | |
| Domain | PTPc | 9.38e-04 | 36 | 228 | 4 | SM00194 | |
| Domain | EGF-like_dom | CLEC18A RELN LRP1B ATRAID IMPG2 CLEC18C CELSR3 PRF1 TENM1 LRP4 | 1.01e-03 | 249 | 228 | 10 | IPR000742 |
| Domain | MAM | 1.08e-03 | 17 | 228 | 3 | SM00137 | |
| Domain | - | 1.09e-03 | 95 | 228 | 6 | 2.60.120.200 | |
| Domain | C2 | 1.14e-03 | 131 | 228 | 7 | PF00168 | |
| Domain | EGF_1 | CLEC18A RELN LRP1B ATRAID IMPG2 CLEC18C CELSR3 PRF1 TENM1 LRP4 | 1.20e-03 | 255 | 228 | 10 | PS00022 |
| Domain | TYR_PHOSPHATASE_PTP | 1.27e-03 | 39 | 228 | 4 | PS50055 | |
| Domain | - | 1.27e-03 | 39 | 228 | 4 | 2.120.10.30 | |
| Domain | MAM | 1.28e-03 | 18 | 228 | 3 | PF00629 | |
| Domain | G_crystallin-rel | 1.28e-03 | 18 | 228 | 3 | IPR011024 | |
| Domain | MAM_dom | 1.28e-03 | 18 | 228 | 3 | IPR000998 | |
| Domain | MAM_2 | 1.28e-03 | 18 | 228 | 3 | PS50060 | |
| Domain | VWF_A | 1.35e-03 | 99 | 228 | 6 | IPR002035 | |
| Domain | C2 | 1.48e-03 | 137 | 228 | 7 | SM00239 | |
| Pathway | REACTOME_ENDOSOMAL_VACUOLAR_PATHWAY | 2.82e-06 | 9 | 176 | 4 | MM14527 | |
| Pathway | REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK | 3.50e-06 | 52 | 176 | 7 | MM14743 | |
| Pathway | BIOCARTA_CTL_PATHWAY | 3.82e-06 | 20 | 176 | 5 | MM1374 | |
| Pathway | REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK | 8.28e-06 | 59 | 176 | 7 | M11215 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SOD1_TO_RETROGRADE_AXONAL_TRANSPORT | 1.85e-05 | 27 | 176 | 5 | M47755 | |
| Pathway | REACTOME_CELL_DEATH_SIGNALLING_VIA_NRAGE_NRIF_AND_NADE | 2.59e-05 | 70 | 176 | 7 | MM14824 | |
| Pathway | PID_CDC42_REG_PATHWAY | 3.17e-05 | 30 | 176 | 5 | M83 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_KSHV_MIR1_2_TO_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES | 3.72e-05 | 6 | 176 | 3 | M47468 | |
| Pathway | REACTOME_CELL_DEATH_SIGNALLING_VIA_NRAGE_NRIF_AND_NADE | 4.44e-05 | 76 | 176 | 7 | M19832 | |
| Pathway | REACTOME_G_ALPHA_12_13_SIGNALLING_EVENTS | 4.84e-05 | 77 | 176 | 7 | MM15044 | |
| Pathway | REACTOME_DAP12_INTERACTIONS | 5.47e-05 | 54 | 176 | 6 | MM14871 | |
| Pathway | REACTOME_G_ALPHA_12_13_SIGNALLING_EVENTS | 6.19e-05 | 80 | 176 | 7 | M800 | |
| Pathway | REACTOME_ER_PHAGOSOME_PATHWAY | 6.27e-05 | 18 | 176 | 4 | MM14525 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HTLV_1_P12_TO_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES | 6.45e-05 | 7 | 176 | 3 | M47582 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E5_TO_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES | 6.45e-05 | 7 | 176 | 3 | M47530 | |
| Pathway | REACTOME_P75_NTR_RECEPTOR_MEDIATED_SIGNALLING | 9.13e-05 | 85 | 176 | 7 | MM14746 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RETROGRADE_AXONAL_TRANSPORT | 1.88e-04 | 43 | 176 | 5 | M47669 | |
| Pathway | REACTOME_P75_NTR_RECEPTOR_MEDIATED_SIGNALLING | 2.10e-04 | 97 | 176 | 7 | M9400 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_RETROGRADE_AXONAL_TRANSPORT | 2.34e-04 | 45 | 176 | 5 | M47670 | |
| Pathway | REACTOME_ANTIGEN_PRESENTATION_FOLDING_ASSEMBLY_AND_PEPTIDE_LOADING_OF_CLASS_I_MHC | 2.42e-04 | 25 | 176 | 4 | MM15713 | |
| Pathway | BIOCARTA_NKCELLS_PATHWAY | 2.42e-04 | 25 | 176 | 4 | MM1465 | |
| Pathway | REACTOME_ENDOSOMAL_VACUOLAR_PATHWAY | 2.93e-04 | 11 | 176 | 3 | M525 | |
| Pathway | KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY | 3.21e-04 | 137 | 176 | 8 | M5669 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES | 3.87e-04 | 12 | 176 | 3 | M47529 | |
| Pubmed | Recognition of the ligand-type specificity of classical and non-classical MHC I proteins. | 7.76e-12 | 9 | 237 | 6 | 22001201 | |
| Pubmed | CFH TNFRSF25 CHAF1B RELN GALNT2 HLA-A HLA-B KIAA0319L LRP1B MTMR10 TERF2IP SETDB1 PTPRD PTPRK MIB1 FIP1L1 DHX35 CARS2 SMURF2 SORBS2 TOMM6 DSP SORBS1 WRAP53 PRPF8 EEF1A1 CELSR3 KHDRBS1 CIAO3 LRP4 SMAD2 PINK1 | 2.85e-10 | 1285 | 237 | 32 | 35914814 | |
| Pubmed | 2.93e-10 | 7 | 237 | 5 | 15304010 | ||
| Pubmed | Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors. | GALNT2 HLA-A HLA-B CCT3 HLA-C GARS1 NAGLU HLA-H SSR4 NRP1 ACSL3 GANAB PTPRK AEBP1 FIP1L1 LOXL4 CARS2 DNAH6 SEC23B ABCC1 CHERP SEMA7A DSP DDR2 OAS2 PRPF8 CLSTN1 EEF1A1 AKR7A2 PLA2R1 TGM3 IGF2R TLE1 CST2 | 3.64e-10 | 1451 | 237 | 34 | 30550785 |
| Pubmed | 7.76e-10 | 8 | 237 | 5 | 16123136 | ||
| Pubmed | 7.76e-10 | 8 | 237 | 5 | 28096300 | ||
| Pubmed | Programmed death 1 protects from fatal circulatory failure during systemic virus infection of mice. | 1.74e-09 | 9 | 237 | 5 | 23230000 | |
| Pubmed | Constraints in antigen presentation severely restrict T cell recognition of the allogeneic fetus. | 1.74e-09 | 9 | 237 | 5 | 17446933 | |
| Pubmed | 1.74e-09 | 9 | 237 | 5 | 10081226 | ||
| Pubmed | In vivo conversion of BM plasmacytoid DC into CD11b+ conventional DC during virus infection. | 1.74e-09 | 9 | 237 | 5 | 18979509 | |
| Pubmed | 1.74e-09 | 9 | 237 | 5 | 7141491 | ||
| Pubmed | MICA polymorphism in a population from north Morocco, Metalsa Berbers, using sequence-based typing. | 2.10e-09 | 4 | 237 | 4 | 16216678 | |
| Pubmed | 2.10e-09 | 4 | 237 | 4 | 2715640 | ||
| Pubmed | Distribution of MICA alleles and haplotypes associated with HLA in the Korean population. | 2.10e-09 | 4 | 237 | 4 | 12590984 | |
| Pubmed | MICA 5.1 allele is a susceptibility marker for psoriasis in the Korean population. | 2.10e-09 | 4 | 237 | 4 | 11169245 | |
| Pubmed | 2.10e-09 | 4 | 237 | 4 | 20097244 | ||
| Pubmed | 3.45e-09 | 10 | 237 | 5 | 22124325 | ||
| Pubmed | 3.45e-09 | 10 | 237 | 5 | 18768900 | ||
| Pubmed | 3.45e-09 | 10 | 237 | 5 | 2573520 | ||
| Pubmed | Cellular inhibitor of apoptosis proteins prevent clearance of hepatitis B virus. | 1.07e-08 | 12 | 237 | 5 | 25902529 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | NAGLU KIAA0319L OBSCN RYR1 RHPN1 GLI1 BANP NAV1 TP53I13 CACNA1H MCF2L D2HGDH SMURF2 RIC1 CRYBG2 SEMA7A UBE3B AKNA WRAP53 TRIM7 ACTR1A IGF2R CELSR3 ENTPD2 HELZ2 LRP4 RAI1 | 1.17e-08 | 1105 | 237 | 27 | 35748872 |
| Pubmed | Mapping of the L-methylmalonyl-CoA mutase gene to mouse chromosome 17. | 1.73e-08 | 13 | 237 | 5 | 1970332 | |
| Pubmed | Regulation of activated CD4+ T cells by NK cells via the Qa-1-NKG2A inhibitory pathway. | 1.73e-08 | 13 | 237 | 5 | 17509909 | |
| Pubmed | 2.68e-08 | 14 | 237 | 5 | 3745925 | ||
| Pubmed | 4.00e-08 | 15 | 237 | 5 | 21964024 | ||
| Pubmed | Control of Viral Infection by Natural Killer Cell Inhibitory Receptors. | 5.79e-08 | 16 | 237 | 5 | 32726632 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | CFH HFE GALNT2 HLA-A HLA-B HLA-C NAGLU KIAA0319L SSR4 ITGA7 LRP1B NRP1 GANAB PTPRK MICA ABCC1 COL12A1 CLSTN1 SLC6A6 PLA2R1 IGF2R CELSR3 LRP4 FUCA2 DCBLD2 CDH13 SMAD2 | 6.43e-08 | 1201 | 237 | 27 | 35696571 |
| Pubmed | 7.24e-08 | 7 | 237 | 4 | 2808323 | ||
| Pubmed | Direct link between mhc polymorphism, T cell avidity, and diversity in immune defense. | 7.24e-08 | 7 | 237 | 4 | 12459592 | |
| Pubmed | A saturation hypothesis to explain both enhanced and impaired learning with enhanced plasticity. | 7.24e-08 | 7 | 237 | 4 | 28234229 | |
| Pubmed | 7.24e-08 | 7 | 237 | 4 | 2642506 | ||
| Pubmed | 7.24e-08 | 7 | 237 | 4 | 9037062 | ||
| Pubmed | 7.24e-08 | 7 | 237 | 4 | 20957233 | ||
| Pubmed | 7.24e-08 | 7 | 237 | 4 | 11580250 | ||
| Pubmed | Convergent recombination shapes the clonotypic landscape of the naive T-cell repertoire. | 7.24e-08 | 7 | 237 | 4 | 20974936 | |
| Pubmed | 7.24e-08 | 7 | 237 | 4 | 10704462 | ||
| Pubmed | A novel H-2K splice form: predictions for other alternative H-2 splicing events. | 7.24e-08 | 7 | 237 | 4 | 2908875 | |
| Pubmed | 7.24e-08 | 7 | 237 | 4 | 3458188 | ||
| Pubmed | 7.24e-08 | 7 | 237 | 4 | 19462379 | ||
| Pubmed | 7.24e-08 | 7 | 237 | 4 | 6300887 | ||
| Pubmed | H-2-linked regulation of xenotropic murine leukemia virus expression. | 7.24e-08 | 7 | 237 | 4 | 6300850 | |
| Pubmed | 7.24e-08 | 7 | 237 | 4 | 8500526 | ||
| Pubmed | cDNA clone coding for part of a mouse H-2d major histocompatibility antigen. | 7.24e-08 | 7 | 237 | 4 | 6265910 | |
| Pubmed | DNA polymorphisms defined by the Tu108 probe map to the Tla region of mouse chromosome 17. | 7.24e-08 | 7 | 237 | 4 | 2906539 | |
| Pubmed | 7.24e-08 | 7 | 237 | 4 | 3013627 | ||
| Pubmed | 7.24e-08 | 7 | 237 | 4 | 3894562 | ||
| Pubmed | 7.24e-08 | 7 | 237 | 4 | 1348042 | ||
| Pubmed | H2-K(b) and H2-D(b) regulate cerebellar long-term depression and limit motor learning. | 7.24e-08 | 7 | 237 | 4 | 19346486 | |
| Pubmed | Liver sinusoidal endothelial cells veto CD8 T cell activation by antigen-presenting dendritic cells. | 7.24e-08 | 7 | 237 | 4 | 18383043 | |
| Pubmed | 7.24e-08 | 7 | 237 | 4 | 8833240 | ||
| Pubmed | 7.24e-08 | 7 | 237 | 4 | 21178009 | ||
| Pubmed | Extensive deletions in the Q region of the mouse major histocompatibility complex. | 7.24e-08 | 7 | 237 | 4 | 3025084 | |
| Pubmed | 7.24e-08 | 7 | 237 | 4 | 2989712 | ||
| Pubmed | Unique biochemical properties of a mutant MHC class I molecule, H-2Ksm1. | 7.24e-08 | 7 | 237 | 4 | 1280760 | |
| Pubmed | Three cDNA clones encoding mouse transplantation antigens: homology to immunoglobulin genes. | 7.24e-08 | 7 | 237 | 4 | 6786753 | |
| Pubmed | 7.24e-08 | 7 | 237 | 4 | 6583704 | ||
| Pubmed | 7.24e-08 | 7 | 237 | 4 | 6571712 | ||
| Pubmed | 7.24e-08 | 7 | 237 | 4 | 12006653 | ||
| Pubmed | 7.24e-08 | 7 | 237 | 4 | 7520098 | ||
| Pubmed | 7.24e-08 | 7 | 237 | 4 | 10452993 | ||
| Pubmed | 7.24e-08 | 7 | 237 | 4 | 26714929 | ||
| Pubmed | 7.24e-08 | 7 | 237 | 4 | 6280871 | ||
| Pubmed | 7.24e-08 | 7 | 237 | 4 | 10799615 | ||
| Pubmed | 7.24e-08 | 7 | 237 | 4 | 10993729 | ||
| Pubmed | MHC class I Dk locus and Ly49G2+ NK cells confer H-2k resistance to murine cytomegalovirus. | 7.24e-08 | 7 | 237 | 4 | 19454713 | |
| Pubmed | 7.24e-08 | 7 | 237 | 4 | 10229092 | ||
| Pubmed | 7.24e-08 | 7 | 237 | 4 | 2879284 | ||
| Pubmed | 7.24e-08 | 7 | 237 | 4 | 7306483 | ||
| Pubmed | 7.24e-08 | 7 | 237 | 4 | 2351932 | ||
| Pubmed | Nucleotide sequence analysis of H-2Df and the spontaneous in vivo H-2Dfm2 mutation. | 7.24e-08 | 7 | 237 | 4 | 1731192 | |
| Pubmed | 7.24e-08 | 7 | 237 | 4 | 1627536 | ||
| Pubmed | 7.24e-08 | 7 | 237 | 4 | 32341060 | ||
| Pubmed | H-2 class I and Gt (H-2) antigens are identical: evidence from H-2 mutant mice. | 7.24e-08 | 7 | 237 | 4 | 2422118 | |
| Pubmed | 7.24e-08 | 7 | 237 | 4 | 34181639 | ||
| Pubmed | 7.24e-08 | 7 | 237 | 4 | 15809355 | ||
| Pubmed | Thymus-leukemia (TL) antigens of the mouse. Analysis of TL mRNA and TL cDNA TL+ and TL- strains. | 7.24e-08 | 7 | 237 | 4 | 3840195 | |
| Pubmed | Mouse histocompatibility genes: structure and organisation of a Kd gene. | 7.24e-08 | 7 | 237 | 4 | 11894934 | |
| Pubmed | 7.24e-08 | 7 | 237 | 4 | 19700752 | ||
| Pubmed | 7.24e-08 | 7 | 237 | 4 | 11894963 | ||
| Pubmed | 7.24e-08 | 7 | 237 | 4 | 22287714 | ||
| Pubmed | 7.24e-08 | 7 | 237 | 4 | 2997361 | ||
| Pubmed | 7.24e-08 | 7 | 237 | 4 | 9869916 | ||
| Pubmed | 7.24e-08 | 7 | 237 | 4 | 312902 | ||
| Pubmed | 7.24e-08 | 7 | 237 | 4 | 3335396 | ||
| Pubmed | 7.24e-08 | 7 | 237 | 4 | 6689056 | ||
| Pubmed | 7.24e-08 | 7 | 237 | 4 | 16461341 | ||
| Pubmed | 7.24e-08 | 7 | 237 | 4 | 6895187 | ||
| Pubmed | Genetic control of corticosteroid side-chain isomerase activity in the mouse. | 7.24e-08 | 7 | 237 | 4 | 6822218 | |
| Pubmed | 7.24e-08 | 7 | 237 | 4 | 15210799 | ||
| Pubmed | NK gene complex and chromosome 19 loci enhance MHC resistance to murine cytomegalovirus infection. | 7.24e-08 | 7 | 237 | 4 | 19820922 | |
| Pubmed | 7.24e-08 | 7 | 237 | 4 | 8181071 | ||
| Pubmed | 7.24e-08 | 7 | 237 | 4 | 23142461 | ||
| Pubmed | Structure of C-terminal half of two H-2 antigens from cloned mRNA. | 7.24e-08 | 7 | 237 | 4 | 6895103 | |
| Pubmed | Nucleotide sequences of H2g7 K and D loci of nonobese diabetic mice. | 7.24e-08 | 7 | 237 | 4 | 7759137 | |
| Pubmed | 7.24e-08 | 7 | 237 | 4 | 6799575 | ||
| Pubmed | Qa antigen expression on functional lymphoid, myeloid, and stem cells in adult mice. | 7.24e-08 | 7 | 237 | 4 | 6966299 | |
| Pubmed | 7.24e-08 | 7 | 237 | 4 | 12140378 | ||
| Pubmed | 7.24e-08 | 7 | 237 | 4 | 2410925 | ||
| Pubmed | 7.24e-08 | 7 | 237 | 4 | 12421934 | ||
| Pubmed | 7.24e-08 | 7 | 237 | 4 | 3840763 | ||
| Interaction | RYK interactions | HLA-A KIAA0319L NRP1 PTPRD PTPRK MICB MIB1 MICA SDK1 SECTM1 CELSR3 EPHA7 | 7.05e-06 | 212 | 233 | 12 | int:RYK |
| Interaction | DNASE1L1 interactions | 1.09e-05 | 120 | 233 | 9 | int:DNASE1L1 | |
| Interaction | BRICD5 interactions | HFE HLA-A HLA-C NAGLU ITGA7 GANAB CLSTN1 PRF1 ENTPD2 DCBLD2 EPHA7 | 1.68e-05 | 194 | 233 | 11 | int:BRICD5 |
| Interaction | CD1A interactions | 1.96e-05 | 72 | 233 | 7 | int:CD1A | |
| Interaction | ASIC4 interactions | 2.64e-05 | 134 | 233 | 9 | int:ASIC4 | |
| GeneFamily | Fibronectin type III domain containing | OBSCN DCC FNDC7 PTPRD PTPRK IGSF9 SDK1 COL12A1 FNDC4 PTPRU CSF3R EPHA7 | 2.68e-08 | 160 | 165 | 12 | 555 |
| GeneFamily | C1-set domain containing | 2.11e-06 | 42 | 165 | 6 | 591 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 2.30e-06 | 66 | 165 | 7 | 722 | |
| GeneFamily | Transglutaminases | 6.02e-05 | 9 | 165 | 3 | 773 | |
| GeneFamily | Dyneins, axonemal | 4.62e-04 | 17 | 165 | 3 | 536 | |
| GeneFamily | Chloride channel accessory | 4.91e-04 | 4 | 165 | 2 | 867 | |
| GeneFamily | Histocompatibility complex|C1-set domain containing | 6.83e-04 | 44 | 165 | 4 | 588 | |
| GeneFamily | Protein tyrosine phosphatases, receptor type | 8.80e-04 | 21 | 165 | 3 | 813 | |
| GeneFamily | Immunoglobulin like domain containing | 1.99e-03 | 193 | 165 | 7 | 594 | |
| GeneFamily | Proprotein convertase subtilisin/kexin family | 2.86e-03 | 9 | 165 | 2 | 973 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 3.63e-03 | 161 | 165 | 6 | 593 | |
| GeneFamily | Complement system|Sushi domain containing | 4.27e-03 | 36 | 165 | 3 | 492 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 4.27e-03 | 36 | 165 | 3 | 823 | |
| Coexpression | TABULA_MURIS_SENIS_MESENTERIC_ADIPOSE_TISSUE_B_CELL_AGEING | 7.46e-07 | 82 | 235 | 8 | MM3777 | |
| Coexpression | TABULA_MURIS_SENIS_HEART_ENDOCARDIAL_CELL_AGEING | 9.77e-07 | 59 | 235 | 7 | MM3704 | |
| Coexpression | MIKKELSEN_MCV6_ICP_WITH_H3K27ME3 | 1.08e-06 | 86 | 235 | 8 | MM834 | |
| Coexpression | LEE_CALORIE_RESTRICTION_NEOCORTEX_UP | 1.18e-06 | 87 | 235 | 8 | MM652 | |
| Coexpression | BUSSLINGER_GASTRIC_G_CELLS | 2.91e-06 | 98 | 235 | 8 | M40018 | |
| Coexpression | BAUS_TFF2_TARGETS_UP | 4.94e-06 | 49 | 235 | 6 | MM1287 | |
| Coexpression | SANA_RESPONSE_TO_IFNG_UP | 5.50e-06 | 76 | 235 | 7 | M4551 | |
| Coexpression | KIM_LRRC3B_TARGETS | 6.59e-06 | 30 | 235 | 5 | M17363 | |
| Coexpression | TABULA_MURIS_SENIS_LUNG_ENDOTHELIAL_CELL_OF_LYMPHATIC_VESSEL_AGEING | 1.05e-05 | 16 | 235 | 4 | MM3766 | |
| Coexpression | KUROKAWA_LIVER_CANCER_EARLY_RECURRENCE_DN | 1.40e-05 | 6 | 235 | 3 | M7182 | |
| Coexpression | WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_DN | 2.20e-05 | 19 | 235 | 4 | MM797 | |
| Coexpression | MIKKELSEN_NPC_ICP_WITH_H3K27ME3 | 2.20e-05 | 19 | 235 | 4 | MM862 | |
| Coexpression | TABULA_MURIS_SENIS_LUNG_CD8_POSITIVE_ALPHA_BETA_T_CELL_AGEING | 2.49e-05 | 39 | 235 | 5 | MM3758 | |
| Coexpression | TABULA_MURIS_SENIS_KIDNEY_KIDNEY_CORTEX_ARTERY_CELL_AGEING | 2.49e-05 | 39 | 235 | 5 | MM3725 | |
| Coexpression | GSE15624_3H_VS_6H_HALOFUGINONE_TREATED_CD4_TCELL_UP | 2.54e-05 | 171 | 235 | 9 | M7105 | |
| Coexpression | TABULA_MURIS_SENIS_BLADDER_LEUKOCYTE_AGEING | 2.73e-05 | 20 | 235 | 4 | MM3682 | |
| Coexpression | GSE34156_UNTREATED_VS_6H_NOD2_LIGAND_TREATED_MONOCYTE_DN | 3.33e-05 | 177 | 235 | 9 | M8666 | |
| Coexpression | RUAN_RESPONSE_TO_TNF_UP | 3.34e-05 | 21 | 235 | 4 | MM651 | |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_DN | 4.06e-05 | 103 | 235 | 7 | MM476 | |
| Coexpression | TABULA_MURIS_SENIS_LUNG_TYPE_II_PNEUMOCYTE_AGEING | 4.53e-05 | 44 | 235 | 5 | MM3775 | |
| Coexpression | TABULA_MURIS_SENIS_AORTA_AORTIC_ENDOTHELIAL_CELL_AGEING | CFH HLA-A HLA-B HLA-C OBSCN HLA-H FIP1L1 TOMM6 GSN EEF1A1 CST2 CDH13 | 4.60e-05 | 329 | 235 | 12 | MM3671 |
| Coexpression | SERVITJA_ISLET_HNF1A_TARGETS_UP | 4.70e-05 | 185 | 235 | 9 | MM1072 | |
| Coexpression | TABULA_MURIS_SENIS_SPLEEN_CD8_POSITIVE_ALPHA_BETA_T_CELL_AGEING | 5.11e-05 | 187 | 235 | 9 | MM3833 | |
| Coexpression | TABULA_MURIS_SENIS_HEART_AND_AORTA_ENDOCARDIAL_CELL_AGEING | 5.64e-05 | 46 | 235 | 5 | MM3712 | |
| Coexpression | TABULA_MURIS_SENIS_LUNG_PULMONARY_INTERSTITIAL_FIBROBLAST_AGEING | 5.81e-05 | 24 | 235 | 4 | MM3773 | |
| Coexpression | TABULA_MURIS_SENIS_KIDNEY_BRUSH_CELL_AGEING | 5.85e-05 | 75 | 235 | 6 | MM3718 | |
| Coexpression | BUSSLINGER_GASTRIC_X_CELLS | 6.02e-05 | 191 | 235 | 9 | M40019 | |
| Coexpression | RUAN_RESPONSE_TO_TNF_TROGLITAZONE_UP | 6.87e-05 | 25 | 235 | 4 | MM672 | |
| Coexpression | GSE26488_WT_VS_HDAC7_KO_DOUBLE_POSITIVE_THYMOCYTE_UP | FNBP1L TERF2IP SORBS2 USP37 KLHL31 TRIM7 TGM3 TMEM132D TENM1 | 7.07e-05 | 195 | 235 | 9 | M8194 |
| Coexpression | BENPORATH_ES_WITH_H3K27ME3 | GABRB2 PCSK2 HLA-A HLA-B HLA-C TMEM185A DCC ANKRD27 SORCS1 ARHGEF7 MICB DIO3 VAV3 SECTM1 DRD4 COL12A1 ESAM PTPRU CR2 GRM7 GSN TRIM7 SLC6A2 ENTPD2 | 7.10e-05 | 1115 | 235 | 24 | M10371 |
| Coexpression | GSE360_CTRL_VS_M_TUBERCULOSIS_MAC_UP | 7.94e-05 | 198 | 235 | 9 | M5170 | |
| Coexpression | GSE360_LOW_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_MAC_UP | 8.26e-05 | 199 | 235 | 9 | M5266 | |
| Coexpression | GSE43955_1H_VS_20H_ACT_CD4_TCELL_WITH_TGFB_IL6_DN | 8.58e-05 | 200 | 235 | 9 | M9677 | |
| Coexpression | GSE36009_UNSTIM_VS_LPS_STIM_DC_DN | 8.58e-05 | 200 | 235 | 9 | M8774 | |
| Coexpression | GSE339_EX_VIVO_VS_IN_CULTURE_CD8POS_DC_UP | 8.58e-05 | 200 | 235 | 9 | M5131 | |
| Coexpression | HALLMARK_MYOGENESIS | 8.58e-05 | 200 | 235 | 9 | M5909 | |
| Coexpression | SANA_TNF_SIGNALING_UP | 1.03e-04 | 83 | 235 | 6 | M17466 | |
| Coexpression | TABULA_MURIS_SENIS_HEART_VENTRICULAR_MYOCYTE_AGEING | 1.07e-04 | 120 | 235 | 7 | MM3710 | |
| Coexpression | ZENG_GU_POST_ICB_METAGENE_31 | 1.20e-04 | 209 | 235 | 9 | MM17088 | |
| Coexpression | BUSSLINGER_DUODENAL_MATURE_ENTEROCYTES | CYP3A4 CDHR2 HAPLN4 IGSF9 BAIAP2L2 SECTM1 MICAL1 CRYBG2 LCT MISP | 1.25e-04 | 259 | 235 | 10 | M40029 |
| Coexpression | BOQUEST_STEM_CELL_CULTURED_VS_FRESH_UP | CFH LRP1B GGT5 PTPRD AEBP1 EIF2S2 KIF13B DSP MAP3K8 SORBS1 GSN HAPLN1 TENM1 | 1.39e-04 | 427 | 235 | 13 | M17923 |
| Coexpression | TABULA_MURIS_SENIS_TONGUE_KERATINOCYTE_AGEING | 1.46e-04 | 56 | 235 | 5 | MM3852 | |
| Coexpression | TABULA_MURIS_SENIS_HEART_AND_AORTA_SMOOTH_MUSCLE_CELL_AGEING | 1.59e-04 | 57 | 235 | 5 | MM3716 | |
| Coexpression | COATES_MACROPHAGE_M1_VS_M2_DN | 1.62e-04 | 90 | 235 | 6 | MM750 | |
| Coexpression | TABULA_MURIS_SENIS_KIDNEY_KIDNEY_MESANGIAL_CELL_AGEING | 1.64e-04 | 31 | 235 | 4 | MM3729 | |
| Coexpression | TABULA_MURIS_SENIS_LIMB_MUSCLE_SMOOTH_MUSCLE_CELL_AGEING | 1.83e-04 | 92 | 235 | 6 | MM3748 | |
| Coexpression | MIKKELSEN_MEF_ICP_WITH_H3K27ME3 | 1.95e-04 | 223 | 235 | 9 | MM838 | |
| Coexpression | BENPORATH_EED_TARGETS | GABRB2 TNFRSF25 RELN HLA-A HLA-B HLA-C BACH2 DCC ANKRD27 SORCS1 ANKRD13C MICB DIO3 DRD4 COL12A1 DSP ESAM PTPRU GRM7 TRIM7 PHF3 FUCA2 | 2.36e-04 | 1059 | 235 | 22 | M7617 |
| Coexpression | DESCARTES_ORGANOGENESIS_CHONDROCYTE_PROGENITORS | 2.37e-04 | 62 | 235 | 5 | MM3645 | |
| Coexpression | TABULA_MURIS_SENIS_MAMMARY_GLAND_MACROPHAGE_AGEING | 2.44e-04 | 97 | 235 | 6 | MM3789 | |
| Coexpression | PAL_PRMT5_TARGETS_DN | 2.65e-04 | 35 | 235 | 4 | MM674 | |
| Coexpression | KRAS.LUNG.BREAST_UP.V1_DN | 2.91e-04 | 141 | 235 | 7 | M2898 | |
| Coexpression | WONG_ADULT_TISSUE_STEM_MODULE | RELN LPIN1 PTPRK NAV1 ABCC1 PCLO ESAM PTPN21 CR2 SLC6A6 IGF2R CELSR3 FRMD6 TLE1 LRP4 RAI1 EPHA7 | 2.97e-04 | 721 | 235 | 17 | M1999 |
| Coexpression | PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_DN | TNFRSF25 CYP3A4 HAPLN4 ADGRV1 RYR1 ANKRD13C DNAH9 AKNA PTPN21 HAPLN1 CRYBA1 RBM6 | 3.06e-04 | 403 | 235 | 12 | M2367 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNBM | 3.54e-04 | 295 | 235 | 10 | M39063 | |
| Coexpression | GSE37416_CTRL_VS_48H_F_TULARENSIS_LVS_NEUTROPHIL_UP | 3.69e-04 | 193 | 235 | 8 | M5339 | |
| Coexpression | GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_24H_ACT_CD4_TCELL_DN | 3.82e-04 | 194 | 235 | 8 | M4227 | |
| Coexpression | SABATES_COLORECTAL_ADENOMA_DN | CFH CYP3A4 CHRNA1 SORCS1 SECTM1 CLCA4 SORBS2 CR2 HAPLN1 EPHA7 | 3.94e-04 | 299 | 235 | 10 | M14791 |
| Coexpression | LOPEZ_MBD_TARGETS | HLA-B CCT3 PSMA1 ENTR1 GARS1 KIAA0319L SLC15A3 RYR1 GANAB ATRAID EIF2S2 FIP1L1 FGFR3 SECTM1 SORBS1 PTPRU ACTR1B ACTR1A CSF3R GOLGA6L9 | 4.00e-04 | 953 | 235 | 20 | M4120 |
| Coexpression | PILON_KLF1_TARGETS_UP | CYP2D6 HLA-B HLA-C HLA-H SETDB1 PTPRD AEBP1 MIB1 LOXL4 RIC1 ESAM TMEM132D DCBLD2 NLK | 4.08e-04 | 541 | 235 | 14 | MM1061 |
| Coexpression | GSE24814_STAT5_KO_VS_WT_PRE_BCELL_UP | 4.23e-04 | 197 | 235 | 8 | M8426 | |
| Coexpression | GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_10H_DN | 4.23e-04 | 197 | 235 | 8 | M4294 | |
| Coexpression | GSE22886_NAIVE_BCELL_VS_MONOCYTE_UP | 4.23e-04 | 197 | 235 | 8 | M4485 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | GABRB2 RELN BACH2 FNBP1L DCC LRP1B TERF2IP LPIN1 PTPRK NAV1 VAV3 MCF2L VAV2 PCLO SORBS1 GRM7 CELSR3 SH3PXD2A TENM1 CDH13 NLK RAI1 | 4.27e-04 | 1106 | 235 | 22 | M39071 |
| Coexpression | GSE27786_NEUTROPHIL_VS_MONO_MAC_UP | 4.52e-04 | 199 | 235 | 8 | M4880 | |
| Coexpression | GSE42021_CD24HI_VS_CD24LOW_TCONV_THYMUS_DN | 4.52e-04 | 199 | 235 | 8 | M9595 | |
| Coexpression | GSE1460_INTRATHYMIC_T_PROGENITOR_VS_CD4_THYMOCYTE_DN | 4.52e-04 | 199 | 235 | 8 | M3440 | |
| Coexpression | GSE45739_UNSTIM_VS_ACD3_ACD28_STIM_NRAS_KO_CD4_TCELL_DN | 4.52e-04 | 199 | 235 | 8 | M9885 | |
| Coexpression | GSE23308_WT_VS_MINERALCORTICOID_REC_KO_MACROPHAGE_CORTICOSTERONE_TREATED_UP | 4.52e-04 | 199 | 235 | 8 | M7736 | |
| Coexpression | GSE11961_MARGINAL_ZONE_BCELL_VS_GERMINAL_CENTER_BCELL_DAY7_DN | 4.68e-04 | 200 | 235 | 8 | M9321 | |
| Coexpression | GSE11961_MEMORY_BCELL_DAY7_VS_GERMINAL_CENTER_BCELL_DAY7_UP | 4.68e-04 | 200 | 235 | 8 | M9319 | |
| Coexpression | GSE12198_LOW_IL2_STIM_NK_CELL_VS_HIGH_IL2_STIM_NK_CELL_UP | 4.68e-04 | 200 | 235 | 8 | M7064 | |
| Coexpression | GSE17721_PAM3CSK4_VS_GADIQUIMOD_12H_BMDC_DN | 4.68e-04 | 200 | 235 | 8 | M3975 | |
| Coexpression | GSE2128_CTRL_VS_MIMETOPE_NEGATIVE_SELECTION_DP_THYMOCYTE_C57BL6_DN | 4.68e-04 | 200 | 235 | 8 | M6185 | |
| Coexpression | GSE2770_IL4_ACT_VS_ACT_CD4_TCELL_48H_DN | 4.68e-04 | 200 | 235 | 8 | M6042 | |
| Coexpression | GSE21670_TGFB_VS_IL6_TREATED_STAT3_KO_CD4_TCELL_DN | 4.68e-04 | 200 | 235 | 8 | M7432 | |
| Coexpression | GSE36392_TYPE_2_MYELOID_VS_NEUTROPHIL_IL25_TREATED_LUNG_UP | 4.68e-04 | 200 | 235 | 8 | M5276 | |
| Coexpression | GSE5142_HTERT_TRANSDUCED_VS_CTRL_CD8_TCELL_LATE_PASSAGE_CLONE_DN | 4.68e-04 | 200 | 235 | 8 | M6552 | |
| Coexpression | GSE5099_UNSTIM_VS_MCSF_TREATED_MONOCYTE_DAY3_DN | 4.68e-04 | 200 | 235 | 8 | M6583 | |
| Coexpression | GSE5099_MONOCYTE_VS_CLASSICAL_M1_MACROPHAGE_DN | 4.68e-04 | 200 | 235 | 8 | M6587 | |
| Coexpression | GSE5503_LIVER_DC_VS_SPLEEN_DC_ACTIVATED_ALLOGENIC_TCELL_UP | 4.68e-04 | 200 | 235 | 8 | M6996 | |
| Coexpression | DESCARTES_ORGANOGENESIS_WHITE_BLOOD_CELLS | CFH HFE HLA-A HLA-B HLA-C HLA-H SLC15A3 ITGAM CD84 ARHGEF6 MAP3K8 OAS2 CSF3R CST2 HELZ2 | 4.74e-04 | 615 | 235 | 15 | MM3641 |
| Coexpression | HOWLIN_CITED1_TARGETS_1_UP | 4.92e-04 | 41 | 235 | 4 | MM710 | |
| Coexpression | FURUKAWA_DUSP6_TARGETS_PCI35_UP | 5.08e-04 | 73 | 235 | 5 | M6998 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | GABRB2 RELN OBSCN ADGRV1 DCC LRP1B SORCS1 PTPRD DNAH9 SDK1 COL12A1 PCLO TENM1 EPHA7 | 1.30e-12 | 184 | 236 | 14 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | GABRB2 RELN OBSCN ADGRV1 DCC LRP1B SORCS1 PTPRD DNAH9 SDK1 COL12A1 PCLO TENM1 EPHA7 | 1.30e-12 | 184 | 236 | 14 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | GABRB2 RELN OBSCN ADGRV1 DCC LRP1B SORCS1 PTPRD DNAH9 SDK1 COL12A1 PCLO TENM1 EPHA7 | 1.30e-12 | 184 | 236 | 14 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | Control-NK|Control / Disease condition and Cell class | HLA-A HLA-B HLA-C ITGAM VAV3 MAP3K8 TFDP2 GSN IGF2R PRF1 TLE1 | 1.01e-08 | 199 | 236 | 11 | f3316fb97c6065286ffd22a0ad9fe7aa5b3b5650 |
| ToppCell | Basal_cells-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 7.97e-08 | 191 | 236 | 10 | a98915bad9a4a61dd4cbca798914849b805f4a19 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_NK|bone_marrow / Manually curated celltypes from each tissue | 1.02e-07 | 196 | 236 | 10 | 1868ad537b7f04cdad0a0c8282aadbc4f257a722 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.17e-07 | 199 | 236 | 10 | ba284f984909504221900bca5ea12ada5b2ffd9f | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.27e-07 | 170 | 236 | 9 | 0cc20322cb3e3e7bbd4daad8785c99f80e355c16 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.27e-07 | 170 | 236 | 9 | 2d880223d01bde4bf777bd6f50b7d2768489075f | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Epithelial-epithelial_progenitor_cell-Proximal_progenitor|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.18e-07 | 175 | 236 | 9 | 6759d200a133034756de9cdf2d5daceca927aac9 | |
| ToppCell | Severe-CD4+_T_activated|Severe / Disease group and Cell class | 4.59e-07 | 177 | 236 | 9 | a08f170f1143fcdd7d0842a54d9b807a4548f8b7 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_ADARB2_ADAM33|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.66e-07 | 185 | 236 | 9 | 487fa382232564f075960899d50afa0edae5d258 | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Capillary_Aerocyte_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.96e-07 | 189 | 236 | 9 | 09dd2b3d89416192e84abe302a6237b8f3fdcb6e | |
| ToppCell | Control-Lymphoid-NK|Lymphoid / Disease state, Lineage and Cell class | 8.32e-07 | 190 | 236 | 9 | 1584c68b58c7f406d9b0e8451beea3e6f8980c56 | |
| ToppCell | Adult-Epithelial-club_cell|Adult / Lineage, Cell type, age group and donor | 8.32e-07 | 190 | 236 | 9 | 756bff697d30aec56c0ebfca94295f084a15bf37 | |
| ToppCell | Control-Endothelial-VE_Capillary_B|Endothelial / Disease state, Lineage and Cell class | 8.32e-07 | 190 | 236 | 9 | 7f3f419fffe02934b6f27b697f7a6401072491ed | |
| ToppCell | Calu_3-infected-SARSCoV2|infected / Cell line, Condition and Strain | 8.69e-07 | 191 | 236 | 9 | 2da876d26f37a00dbdf1ee79d724306e8b20f304 | |
| ToppCell | facs-SCAT-Fat-3m-Endothelial-endothelial_cell|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | FNBP1L NRP1 MCF2L SORBS2 SEMA7A ESAM SORBS1 ST6GALNAC2 CDH13 | 8.69e-07 | 191 | 236 | 9 | 6b9bbf4a63d4e9a8075bb06c2aa644fcf4ee88b8 |
| ToppCell | facs-SCAT-Fat-3m-Endothelial-nan|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | FNBP1L NRP1 MCF2L SORBS2 SEMA7A ESAM SORBS1 ST6GALNAC2 CDH13 | 8.69e-07 | 191 | 236 | 9 | a0018f88f7132477cc467ee15db029a585290595 |
| ToppCell | facs-SCAT-Fat-3m-Endothelial|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | FNBP1L NRP1 MCF2L SORBS2 SEMA7A ESAM SORBS1 ST6GALNAC2 CDH13 | 8.69e-07 | 191 | 236 | 9 | 90f0c193dce267a4f1a9b2501f636dafd0a34cf7 |
| ToppCell | 10x5'-blood-Lymphocytic_NK-NK_CD16|blood / Manually curated celltypes from each tissue | 9.89e-07 | 194 | 236 | 9 | c34a32f1cfe3e597cb0f91ba5bdd3e114e9f3d2e | |
| ToppCell | 10x5'-blood-Lymphocytic_NK|blood / Manually curated celltypes from each tissue | 1.03e-06 | 195 | 236 | 9 | c1db871e8e8e8b8d6a5798bc43eaf54e102b75eb | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 1.03e-06 | 195 | 236 | 9 | 633c7668fe365f7b0f7851cdc442d5dd89c454e2 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Neuronal-Glial_immature-Glia_1_(DHH+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | PCSK2 RELN SLC15A3 SLC22A17 SORCS1 MPZ SORBS2 ST6GALNAC2 ENTPD2 | 1.08e-06 | 196 | 236 | 9 | e6adcfe1a00d4910e0b92848f8a80224e0d6db12 |
| ToppCell | IPF-Endothelial-VE_Capillary_B|Endothelial / Disease state, Lineage and Cell class | 1.08e-06 | 196 | 236 | 9 | 8f0f72ead06abe02b575e443552eacc2151077ef | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Epithelial-Epithelial,_Airway-secretory_cell|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.12e-06 | 197 | 236 | 9 | d6c9da7a3a6d2bcb13e2fc6605c8a59e7fb121c5 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.12e-06 | 197 | 236 | 9 | d9e196c8b4a6ede4733946dbdba3331534954beb | |
| ToppCell | COPD-Endothelial-VE_Capillary_B|Endothelial / Disease state, Lineage and Cell class | 1.12e-06 | 197 | 236 | 9 | 30dbc05ea66892d2e18ff375ffa86d1db7bc4083 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.12e-06 | 197 | 236 | 9 | 2e3d64648a1e4f01b9256a96b94b8a640ee1824c | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Epithelial-Epithelial,_Airway-secretory_cell-Epi-Secretory|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.12e-06 | 197 | 236 | 9 | 80b05c8ad9c1edc5dea3236079372475431343fe | |
| ToppCell | COVID-19_Severe-NK|COVID-19_Severe / Disease condition and Cell class | 1.17e-06 | 198 | 236 | 9 | 742c4d6016cfa48444a5919a885ab8d02cad7e18 | |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 1.17e-06 | 198 | 236 | 9 | df3de77216f5c5d6141ec44d01c56b942f611838 | |
| ToppCell | distal-1-mesenchymal-Myofibroblast|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.22e-06 | 199 | 236 | 9 | 58c36f5a30c6862b7f5587a0b9bc31da99e43dd5 | |
| ToppCell | mild_COVID-19-NK|mild_COVID-19 / disease group, cell group and cell class (v2) | 1.22e-06 | 199 | 236 | 9 | 4854f25ee436e1cf577744373ffd87b1221d2b88 | |
| ToppCell | Tracheal-NucSeq-Stromal-Chondrocytic-Chondrocyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.27e-06 | 200 | 236 | 9 | f5bd0b30e478dac09f68c46b0781f5f2e7e3c693 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW12-Macroglial|GW12 / Sample Type, Dataset, Time_group, and Cell type. | 1.27e-06 | 200 | 236 | 9 | be1abe5bb1ce4e7dfec63af4ed0fc5b96bf77866 | |
| ToppCell | Tracheal-NucSeq-Stromal-Chondrocytic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.27e-06 | 200 | 236 | 9 | b5a54b9baf79aea01f76a161f0a39bbe87eb4945 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo-stroma-osteochondral_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.27e-06 | 200 | 236 | 9 | ad3fb8ef0be45032369d1325024787fbe1dfb8d6 | |
| ToppCell | MS-Multiple_Sclerosis-Lymphocyte-T/NK-MAIT|Multiple_Sclerosis / Disease, condition lineage and cell class | 1.27e-06 | 200 | 236 | 9 | 10120f474ac3de10fc8e66158969415bd3f8c1da | |
| ToppCell | COVID-19_Mild-NK|COVID-19_Mild / Disease condition and Cell class | 1.27e-06 | 200 | 236 | 9 | b586b0f1127293c2f8529be16b24229359041da2 | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.51e-06 | 162 | 236 | 8 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | Ciliated_cells-B-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 2.75e-06 | 164 | 236 | 8 | 0e9961acbb1d6c0089e6805ba6756736fa4d8bed | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Neural-neural_cell-Schwann_Cell_/_Neural-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.01e-06 | 166 | 236 | 8 | f742d15b02a6f651bbd00f53e3d871f40d05a03d | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Neural|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.01e-06 | 166 | 236 | 8 | 0f013bb5fdb72e88c2fc73d60cd01551a2db6341 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Neural-neural_cell-Schwann_Cell_/_Neural|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.01e-06 | 166 | 236 | 8 | e941df9a1091164edde3def8fc7d410186b2bd88 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Neural-neural_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.01e-06 | 166 | 236 | 8 | aeda46bea5d8463c24a83b98b9ed92d962d733e5 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.44e-06 | 169 | 236 | 8 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.92e-06 | 172 | 236 | 8 | ab1c81be29f93ca8920c6ab5ab92f497a9256d3f | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.92e-06 | 172 | 236 | 8 | 1ef243bce63d841c25e4b74d029d1377f84bcc3d | |
| ToppCell | facs-Aorta|facs / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.64e-06 | 176 | 236 | 8 | 0b3491451be02c18a16cdb875645be47eb867a7f | |
| ToppCell | Adult-Epithelial-club_cell-D122|Adult / Lineage, Cell type, age group and donor | 5.04e-06 | 178 | 236 | 8 | 35a2e3ba98b6f857dbb79cf8ddb4846ddcda6c17 | |
| ToppCell | Severe-CD4+_T_activated|World / Disease group and Cell class | 5.04e-06 | 178 | 236 | 8 | ef6111238703579a34bd6948bd9d4ca6b7e16063 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L5_PT-L5_PT_VISp_C1ql2_Ptgfr|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.23e-06 | 127 | 236 | 7 | fb58f4b4d3722f4b9a2e4946c0244c5b70dd883b | |
| ToppCell | COVID-19-kidney-Epi_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 5.26e-06 | 179 | 236 | 8 | e7c9dc63f03d3f3746b51a7e3c8393089e2ceb7d | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.26e-06 | 179 | 236 | 8 | 7954c0026754ab869b88ab7feb13c2f27d6e272d | |
| ToppCell | PCW_07-8.5-Neuronal-Neuronal_postreplicative-neuro_migrating_neuronal_(3)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 5.26e-06 | 179 | 236 | 8 | df6d2cdc4e204ce1a4628dc71dfbc5e6c6309b2a | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_119|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.48e-06 | 180 | 236 | 8 | ea7a1ccf0dd3bb5af5df87501f873e7339a824b3 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.48e-06 | 180 | 236 | 8 | 5391d23817f5cc88a0871ddb98968897c839f464 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.48e-06 | 180 | 236 | 8 | f2f6e83127a4a415e65c76a35efa8175fbd5b5d9 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_ADARB2_ADAM33|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.70e-06 | 181 | 236 | 8 | 2f3d04d22d4ac016e61709ea5af3d48885c946c4 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.70e-06 | 181 | 236 | 8 | 08f44323bf71b6004a921bbc969c954c75feeb66 | |
| ToppCell | normal_Lung-Fibroblasts-Pericytes|normal_Lung / Location, Cell class and cell subclass | 5.70e-06 | 181 | 236 | 8 | f74941e49950027360d71ea3b205fc20c6929766 | |
| ToppCell | wk_15-18-Epithelial-PNS-Late_Schwann|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 5.94e-06 | 182 | 236 | 8 | 6462e0469224457e249d10e224082f727caa02d6 | |
| ToppCell | 343B-Lymphocytic-CD4_T-cell-Treg_cell_1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 6.18e-06 | 183 | 236 | 8 | 807d64deaf4e50dccf6f831f88578a6d903c1421 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.43e-06 | 184 | 236 | 8 | e061e85c4bb19f49f6451ddd7a9077d7378ee365 | |
| ToppCell | PCW_13-14-Neuronal|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 6.43e-06 | 184 | 236 | 8 | 65cf3460125e3dbc34978957bc138a449f71f7df | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.43e-06 | 184 | 236 | 8 | 226ccac00ac1c3a0ad7283785fd14312320e0ca6 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Epithelial-neuro-epithelial-EECs|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.70e-06 | 185 | 236 | 8 | d42f6722a6771752cd744146a09e2ead9b7252bc | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l20-1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.70e-06 | 185 | 236 | 8 | d5f5866924648a3c14e2596218fd548a31777aa3 | |
| ToppCell | 343B-Lymphocytic-CD4_T-cell-Treg_cell_1|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 6.97e-06 | 186 | 236 | 8 | 76cbc3610aedf8c19c17ad5faf6ef5e8980b6af5 | |
| ToppCell | PCW_05-06-Neuronal|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 7.24e-06 | 187 | 236 | 8 | 03a2ed85b171c887d4f3b0f4fe2e1cb4a853e658 | |
| ToppCell | facs-Aorta-Heart-3m-Endothelial-nan|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.24e-06 | 187 | 236 | 8 | df0279b7e94e26f5541b0e2a0ce56befa96ec8ca | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.53e-06 | 188 | 236 | 8 | 0f426cca2ad7671fed9c6d2aa09f6a8627a518cd | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Neuronal|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.53e-06 | 188 | 236 | 8 | ccd2541892112a7a303f766adf9a7afeb754498c | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.53e-06 | 188 | 236 | 8 | aec7485f1a9412bd3a62b70c801cb7f8dcca232d | |
| ToppCell | droplet-Lung-LUNG-30m-Mesenchymal-adventitial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.83e-06 | 189 | 236 | 8 | 6b3b42d758b63a0df62310c34fa3bde421c1afd7 | |
| ToppCell | droplet-Lung-LUNG-30m-Mesenchymal-Adventitial_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.83e-06 | 189 | 236 | 8 | 344b23d3c47d0665dda1cd4856a5e72f1c28cfb3 | |
| ToppCell | facs-Heart-RV-3m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.14e-06 | 190 | 236 | 8 | 89d1d686cc683206534e2157554d7d0df5d53497 | |
| ToppCell | facs-Heart-RV-3m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.14e-06 | 190 | 236 | 8 | 65ba6c4f4a2905c0bf4ff99518ae49e3dfd5e640 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.14e-06 | 190 | 236 | 8 | 26843ec1d19ac85a50990705353b802745d33e4d | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-secretory_cell-Epi-Secretory|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.78e-06 | 192 | 236 | 8 | 8899d81306770adda893b5e146df1253971754c5 | |
| ToppCell | IPF-Epithelial-Basal|World / Disease state, Lineage and Cell class | 8.78e-06 | 192 | 236 | 8 | 9b91e0b162e6f3ce86dd15cc33c2e745d069581f | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.78e-06 | 192 | 236 | 8 | d3c1ad4667a1e223a83ca0fcd5991a0b96f1199a | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-secretory_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.78e-06 | 192 | 236 | 8 | 5fda9a465c9f77c7fa1a3ea07a2b0374bbc23b2a | |
| ToppCell | (5)_Epithelial_cells-(5)_Epi_upper|(5)_Epithelial_cells / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 8.78e-06 | 192 | 236 | 8 | 69b6b3ceaad6432c46d1bc2a00b8389069a8876e | |
| ToppCell | CD8+_Memory_T_cell-CV-0|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 9.12e-06 | 193 | 236 | 8 | 995781d87a919c0380750878bafe584342bb83ad | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Neuronal-Glial_immature-Differentiating_glia|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.12e-06 | 193 | 236 | 8 | d5930f7bd9b299f792212d40a3272a37adf64a82 | |
| ToppCell | facs-Heart-RA-3m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.12e-06 | 193 | 236 | 8 | e7805e866339f676e3f770980c2e0a649eff472e | |
| ToppCell | cellseq2-Epithelial-Epithelial_Airway-Basal/Suprabasal|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.12e-06 | 193 | 236 | 8 | 7c34abdcb8839b9fb25457a79af6c5e7b9714b21 | |
| ToppCell | facs-Heart-RA-3m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.12e-06 | 193 | 236 | 8 | 1ad941098f1a44a46c2f6ebff32a98ada32c80ab | |
| ToppCell | COPD-Lymphoid-NK|Lymphoid / Disease state, Lineage and Cell class | 9.12e-06 | 193 | 236 | 8 | 0020249fa71afb500af73700543bb6f349be6b10 | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_NK|bone_marrow / Manually curated celltypes from each tissue | 9.12e-06 | 193 | 236 | 8 | e790ab76c12f74a13936c231076f1e397283efb3 | |
| ToppCell | 3'-Adult-LargeIntestine-Epithelial-goblet|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.47e-06 | 194 | 236 | 8 | 1a188e52f2f0b6eca3e8d4a4671d9beab0fbbb88 | |
| ToppCell | NS-critical-d_07-13-Epithelial-Squamous|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 9.47e-06 | 194 | 236 | 8 | 53a34843d529ef395deb27086f71f7049a087bab | |
| ToppCell | control-Myeloid-Neutrophils_2|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 9.47e-06 | 194 | 236 | 8 | 267e213e8efe53aadfe553a2ca010a0e3b4b8939 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_neuro-secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.47e-06 | 194 | 236 | 8 | 2dcc3b99dbedaf8a6916891c85091ddb79d7ee31 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.47e-06 | 194 | 236 | 8 | e03ba6caed59fa64d4d9b042593469d4a6a3dc10 | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_NK-NK_CD16|bone_marrow / Manually curated celltypes from each tissue | 9.47e-06 | 194 | 236 | 8 | 7773501e076d470158dbc1d7f10c67152b326eb7 | |
| ToppCell | 10x5'-Liver-Lymphocytic_NK|Liver / Manually curated celltypes from each tissue | 9.47e-06 | 194 | 236 | 8 | 0b78f4ed84bbaca9f72f005c16c7492bb01d4328 | |
| ToppCell | 3'_v3-blood-Lymphocytic_NK-NK_CD16|blood / Manually curated celltypes from each tissue | 9.83e-06 | 195 | 236 | 8 | 789149fb52d9d16393e1649358515add60d37f2d | |
| Computational | Genes in the cancer module 143. | 3.36e-05 | 14 | 151 | 4 | MODULE_143 | |
| Computational | Genes in the cancer module 27. | HFE TNFRSF25 HLA-A HLA-B HLA-C ITGAM RYR1 CHRNE NRP1 FGFR3 DRD4 DDR2 CR2 PLA2R1 CSF3R EPHA7 | 3.79e-05 | 355 | 151 | 16 | MODULE_27 |
| Computational | Porins / transporters. | TNFRSF25 ITGAM RYR1 CHRNE NRP1 PTPRK FGFR3 DDR2 PLA2R1 CSF3R EPHA7 | 1.87e-04 | 211 | 151 | 11 | MODULE_63 |
| Drug | lamotrigine | HLA-B CYP3A4 RYR1 SCNN1D NAV1 LOXL4 CACNA1H TPCN2 SHBG CACNG7 | 3.16e-07 | 116 | 232 | 10 | CID000003878 |
| Drug | trazodone | 8.24e-07 | 51 | 232 | 7 | CID000005533 | |
| Drug | AGEPC | GABRB2 RELN HLA-A EPX ITGAM PARP9 PLCZ1 ESAM PRPF8 HAPLN1 ACTR1B ACTR1A PLA2R1 PAFAH2 NLK | 4.16e-06 | 356 | 232 | 15 | CID000461545 |
| Drug | manidipine | 5.84e-06 | 95 | 232 | 8 | CID000004008 | |
| Drug | C2-O | 6.99e-06 | 13 | 232 | 4 | CID000189691 | |
| Drug | 2-chloro-1,4-dimethoxybenzene | 1.03e-05 | 5 | 232 | 3 | CID000246724 | |
| Drug | t383 | 1.03e-05 | 5 | 232 | 3 | CID000074847 | |
| Drug | NSC603722 | 1.49e-05 | 78 | 232 | 7 | CID005037551 | |
| Drug | LMWH | CFH HGF HLA-A EPX ITGAM PGC CHRNA1 RYR1 CHRNE NRP1 PHKA1 TMPRSS11D FGFR3 ADAMTSL4 IMPG2 COL12A1 PRPF8 HAPLN1 ACTR1B ACTR1A | 1.64e-05 | 663 | 232 | 20 | CID000000772 |
| Drug | bupropion | 1.91e-05 | 81 | 232 | 7 | CID000000444 | |
| Drug | N-desmethyltamoxifen | 2.04e-05 | 6 | 232 | 3 | ctd:C028787 | |
| Drug | 4-methoxymandelic acid | 2.04e-05 | 6 | 232 | 3 | CID000112056 | |
| Drug | N-desmethyltoremifene | 2.04e-05 | 6 | 232 | 3 | CID003035212 | |
| Drug | fluoxetine | GABRB2 CYP2D6 CYP3A4 CHRNA1 CHRNE NRP1 LOXL4 CACNA1H DRD4 FNDC4 SLC6A2 | 2.10e-05 | 225 | 232 | 11 | CID000003386 |
| Drug | Ethotoin [86-35-1]; Up 200; 19.6uM; MCF7; HT_HG-U133A | 3.33e-05 | 195 | 232 | 10 | 6052_UP | |
| Drug | CP-320650-01 [172079-28-6]; Up 200; 1uM; MCF7; HT_HG-U133A | 3.33e-05 | 195 | 232 | 10 | 4382_UP | |
| Drug | Metrizamide [31112-62-6]; Down 200; 5uM; MCF7; HT_HG-U133A | GABRB2 HGF TNFRSF25 CDHR2 KIAA0319L MINAR1 SEMA7A PTPN21 SLC6A6 PAFAH2 | 3.33e-05 | 195 | 232 | 10 | 4156_DN |
| Drug | reduced haloperidol | 3.52e-05 | 37 | 232 | 5 | CID000119265 | |
| Drug | asarol methyl ether | 3.55e-05 | 7 | 232 | 3 | CID000097686 | |
| Drug | Prednisone [53-03-2]; Up 200; 11.2uM; MCF7; HT_HG-U133A | HFE CLCA1 AEBP1 VAV2 GRM7 SLC6A2 SLC6A6 KHDRBS1 PAFAH2 DCBLD2 | 3.96e-05 | 199 | 232 | 10 | 4400_UP |
| Drug | ceric oxide | 4.57e-05 | 39 | 232 | 5 | ctd:C030583 | |
| Disease | Schizophrenia | GABRB2 RELN CYP2D6 HLA-A HLA-B HLA-C PRSS16 CYP3A4 DCC ITGAM SETDB1 MICB NAV1 DIO3 DRD4 ESAM PTPN21 GRM7 GSN SLC6A2 SH3PXD2A RAI1 PINK1 | 4.28e-07 | 883 | 228 | 23 | C0036341 |
| Disease | beta-2 microglobulin measurement | 1.10e-06 | 11 | 228 | 4 | EFO_0005197 | |
| Disease | basophil count | HFE HLA-A HLA-B CCT3 HLA-C BACH2 HLA-H EPX RYR1 GGT5 ABCC1 EEF1A1P5 CSF3R LPO HELZ2 | 6.07e-06 | 483 | 228 | 15 | EFO_0005090 |
| Disease | graft-versus-host disease (implicated_via_orthology) | 1.56e-05 | 7 | 228 | 3 | DOID:0081267 (implicated_via_orthology) | |
| Disease | short-term memory | 4.58e-05 | 83 | 228 | 6 | EFO_0004335 | |
| Disease | Adverse reaction to drug | 4.90e-05 | 84 | 228 | 6 | C0041755 | |
| Disease | Drug toxicity | 4.90e-05 | 84 | 228 | 6 | C0013221 | |
| Disease | – | 5.94e-05 | 2 | 228 | 2 | 608579 | |
| Disease | response to xenobiotic stimulus, Drug-induced agranulocytosis | 5.94e-05 | 2 | 228 | 2 | GO_0009410, HP_0012235 | |
| Disease | Susceptibility to severe cutaneous adverse reaction | 5.94e-05 | 2 | 228 | 2 | cv:C1840548 | |
| Disease | Carbamazepine response | 5.94e-05 | 2 | 228 | 2 | cv:CN077964 | |
| Disease | Major Depressive Disorder | 1.23e-04 | 243 | 228 | 9 | C1269683 | |
| Disease | parental longevity | HLA-A HLA-B HLA-C DCC LRP1B ANKRD27 NRP1 SORCS1 PTPRD PCLO IGF2R CDH13 EPHA7 | 1.36e-04 | 494 | 228 | 13 | EFO_0007796 |
| Disease | gastroesophageal reflux disease | 1.37e-04 | 101 | 228 | 6 | EFO_0003948 | |
| Disease | serum IgE measurement | 1.39e-04 | 64 | 228 | 5 | EFO_0004579 | |
| Disease | natural cytotoxicity triggering receptor 3 measurement | 1.56e-04 | 14 | 228 | 3 | EFO_0008243 | |
| Disease | atopic asthma | 1.68e-04 | 199 | 228 | 8 | EFO_0010638 | |
| Disease | Mental Depression | 1.72e-04 | 254 | 228 | 9 | C0011570 | |
| Disease | EPILEPSY, FAMILIAL TEMPORAL LOBE, 1 | 1.77e-04 | 3 | 228 | 2 | 600512 | |
| Disease | Myasthenic Syndrome, Congenital, Fast-Channel | 1.77e-04 | 3 | 228 | 2 | C1837122 | |
| Disease | Autosomal dominant epilepsy with auditory features | 1.77e-04 | 3 | 228 | 2 | cv:C1838062 | |
| Disease | Ondansetron response | 1.77e-04 | 3 | 228 | 2 | cv:CN417142 | |
| Disease | developmental and epileptic encephalopathy 33 (implicated_via_orthology) | 1.77e-04 | 3 | 228 | 2 | DOID:0080463 (implicated_via_orthology) | |
| Disease | Epilepsy, Familial Temporal Lobe 1 | 1.77e-04 | 3 | 228 | 2 | C4551957 | |
| Disease | Epilepsy, familial temporal lobe, 1 | 1.77e-04 | 3 | 228 | 2 | cv:C4551957 | |
| Disease | Unipolar Depression | 1.99e-04 | 259 | 228 | 9 | C0041696 | |
| Disease | asthma, response to diisocyanate | CHAF1B LRP1B RYR1 PTPRD COL12A1 CLSTN1 TMEM132D SH3PXD2A EPHA7 | 2.10e-04 | 261 | 228 | 9 | EFO_0006995, MONDO_0004979 |
| Disease | SLAM family member 7 measurement | 2.86e-04 | 17 | 228 | 3 | EFO_0008287 | |
| Disease | marginal zone B- and B1-cell-specific protein measurement | 3.53e-04 | 4 | 228 | 2 | EFO_0802730 | |
| Disease | trichloroethylene-induced hypersensitivity | 3.53e-04 | 4 | 228 | 2 | EFO_0007685 | |
| Disease | Stevens-Johnson syndrome (is_implicated_in) | 3.53e-04 | 4 | 228 | 2 | DOID:0050426 (is_implicated_in) | |
| Disease | MYASTHENIC SYNDROME, CONGENITAL, 1A, SLOW-CHANNEL | 3.53e-04 | 4 | 228 | 2 | C4084823 | |
| Disease | Clozapine response | 3.53e-04 | 4 | 228 | 2 | cv:CN077971 | |
| Disease | complement factor H-related protein 3 measurement | 3.58e-04 | 169 | 228 | 7 | EFO_0600056 | |
| Disease | colorectal cancer (is_implicated_in) | 3.66e-04 | 121 | 228 | 6 | DOID:9256 (is_implicated_in) | |
| Disease | Depressive disorder | 4.43e-04 | 289 | 228 | 9 | C0011581 | |
| Disease | Parkinson Disease | 5.23e-04 | 85 | 228 | 5 | C0030567 | |
| Disease | Tinnitus | 5.36e-04 | 130 | 228 | 6 | HP_0000360 | |
| Disease | COVID-19 (is_implicated_in) | 5.46e-04 | 21 | 228 | 3 | DOID:0080600 (is_implicated_in) | |
| Disease | susceptibility to Mycobacterium tuberculosis infection measurement | 5.52e-04 | 86 | 228 | 5 | EFO_0008407 | |
| Disease | fibroblast growth factor receptor 3 measurement | 5.85e-04 | 5 | 228 | 2 | EFO_0020390 | |
| Disease | allergic asthma (is_implicated_in) | 5.85e-04 | 5 | 228 | 2 | DOID:9415 (is_implicated_in) | |
| Disease | level of T-cell surface glycoprotein CD8 alpha chain in blood serum | 5.85e-04 | 5 | 228 | 2 | OBA_2040238 | |
| Disease | galectin-9 measurement | 5.85e-04 | 5 | 228 | 2 | EFO_0021863 | |
| Disease | gamma-aminobutyric acid type B receptor subunit 2 measurement | 5.85e-04 | 5 | 228 | 2 | EFO_0801615 | |
| Disease | monocyte count | HLA-A HLA-B CCT3 HLA-C NAGLU ADGRV1 RYR1 GGT5 CD84 MICB PGBD2 MPZ CRYBG2 UBE3B DDR2 LCT CLSTN1 TFDP2 EEF1A1P5 PLA2R1 CSF3R RAI1 | 6.20e-04 | 1320 | 228 | 22 | EFO_0005091 |
| Disease | Attention Deficit Disorder | 6.29e-04 | 22 | 228 | 3 | C0041671 | |
| Disease | Minimal Brain Dysfunction | 6.29e-04 | 22 | 228 | 3 | C1321905 | |
| Disease | basal cell carcinoma | 6.98e-04 | 189 | 228 | 7 | EFO_0004193 | |
| Disease | retinal vasculature measurement | CFH GARS1 DCC MICA FGFR3 DNAH9 SORBS2 TPCN2 TMEM132D SH3PXD2A SYT14 SMAD2 | 7.47e-04 | 517 | 228 | 12 | EFO_0010554 |
| Disease | telomere length | BANP SCNN1D CACNA1H PLCZ1 CLEC18C TGM1 TMEM132D SH3PXD2A CDH13 | 7.83e-04 | 313 | 228 | 9 | EFO_0004505 |
| Disease | Attention deficit hyperactivity disorder | 8.17e-04 | 24 | 228 | 3 | C1263846 | |
| Disease | MULTIPLE PTERYGIUM SYNDROME, LETHAL TYPE | 8.74e-04 | 6 | 228 | 2 | C1854678 | |
| Disease | peripheral neuropathy, response to bortezomib | 8.74e-04 | 6 | 228 | 2 | EFO_0003100, EFO_0007808 | |
| Disease | endothelial cell-selective adhesion molecule measurement | 8.74e-04 | 6 | 228 | 2 | EFO_0008120 | |
| Disease | lactoperoxidase measurement | 8.74e-04 | 6 | 228 | 2 | EFO_0020525 | |
| Disease | angiopoietin-1 receptor, soluble measurement | 8.74e-04 | 6 | 228 | 2 | EFO_0008023 | |
| Disease | Cataract, Central Saccular, With Sutural Opacities | 8.74e-04 | 6 | 228 | 2 | C1854021 | |
| Disease | glucosidase 2 subunit beta measurement | 8.74e-04 | 6 | 228 | 2 | EFO_0801628 | |
| Disease | ovarian cancer (is_implicated_in) | 9.31e-04 | 56 | 228 | 4 | DOID:2394 (is_implicated_in) | |
| Disease | Takayasu arteritis | 1.06e-03 | 148 | 228 | 6 | EFO_1001857 | |
| Disease | IGA glomerulonephritis | 1.06e-03 | 58 | 228 | 4 | EFO_0004194 | |
| Disease | cadherin-15 measurement | 1.22e-03 | 7 | 228 | 2 | EFO_0020211 | |
| Disease | neutropenia (implicated_via_orthology) | 1.22e-03 | 7 | 228 | 2 | DOID:1227 (implicated_via_orthology) | |
| Disease | trefoil factor 3 measurement | 1.22e-03 | 7 | 228 | 2 | EFO_0008304 | |
| Disease | neuropilin-1 measurement | 1.22e-03 | 7 | 228 | 2 | EFO_0020603 | |
| Disease | Drug-Induced Liver Disease | 1.27e-03 | 404 | 228 | 10 | C0860207 | |
| Disease | Chemical and Drug Induced Liver Injury | 1.27e-03 | 404 | 228 | 10 | C4277682 | |
| Disease | Drug-Induced Acute Liver Injury | 1.27e-03 | 404 | 228 | 10 | C3658290 | |
| Disease | Hepatitis, Toxic | 1.27e-03 | 404 | 228 | 10 | C0019193 | |
| Disease | Chemically-Induced Liver Toxicity | 1.27e-03 | 404 | 228 | 10 | C4279912 | |
| Disease | Hepatitis, Drug-Induced | 1.27e-03 | 404 | 228 | 10 | C1262760 | |
| Disease | eosinophil count | CHAF1B HLA-A HLA-B HLA-C BACH2 EPX GGT5 MICB CACNA1H MICA VAV3 D2HGDH CHERP SCAND2P OAS2 CLSTN1 EEF1A1P5 ACTR1B PLA2R1 LPO HELZ2 SMAD2 RAI1 | 1.28e-03 | 1488 | 228 | 23 | EFO_0004842 |
| Disease | autism spectrum disorder | 1.38e-03 | 156 | 228 | 6 | EFO_0003756 | |
| Disease | Drug-Induced Stevens Johnson Syndrome | 1.43e-03 | 29 | 228 | 3 | C1274933 | |
| Disease | Mycoplasma-Induced Stevens-Johnson Syndrome | 1.43e-03 | 29 | 228 | 3 | C3658301 | |
| Disease | Stevens-Johnson Syndrome Toxic Epidermal Necrolysis Spectrum | 1.43e-03 | 29 | 228 | 3 | C3658302 | |
| Disease | uterine fibroid measurement | 1.43e-03 | 29 | 228 | 3 | EFO_0009410 | |
| Disease | Toxic Epidermal Necrolysis | 1.43e-03 | 29 | 228 | 3 | C0014518 | |
| Disease | cervical cancer (is_implicated_in) | 1.58e-03 | 30 | 228 | 3 | DOID:4362 (is_implicated_in) | |
| Disease | MHC class I polypeptide-related sequence B measurement | 1.58e-03 | 30 | 228 | 3 | EFO_0008234 | |
| Disease | Stevens-Johnson Syndrome | 1.58e-03 | 30 | 228 | 3 | C0038325 | |
| Disease | head and neck squamous cell carcinoma (is_marker_for) | 1.61e-03 | 8 | 228 | 2 | DOID:5520 (is_marker_for) | |
| Disease | anterior uveitis (is_implicated_in) | 1.61e-03 | 8 | 228 | 2 | DOID:1407 (is_implicated_in) | |
| Disease | programmed cell death 1 ligand 2 measurement | 1.61e-03 | 8 | 228 | 2 | EFO_0008268 | |
| Disease | monocyte percentage of leukocytes | HLA-A HLA-B HLA-C BACH2 CHRNE GGT5 SECTM1 PGBD2 CRYBG2 UBE3B EEF1A1P5 DNAH12 CSF3R LPO | 1.76e-03 | 731 | 228 | 14 | EFO_0007989 |
| Disease | squamous cell carcinoma | 1.82e-03 | 67 | 228 | 4 | EFO_0000707 | |
| Disease | depressive symptom measurement | 1.87e-03 | 426 | 228 | 10 | EFO_0007006 | |
| Disease | triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement | 1.91e-03 | 225 | 228 | 7 | EFO_0008317, EFO_0020947 | |
| Disease | vitamin B12 measurement | 1.91e-03 | 32 | 228 | 3 | EFO_0004620 | |
| Disease | diabetes mellitus | 1.92e-03 | 68 | 228 | 4 | EFO_0000400 | |
| Disease | MHC class I polypeptide-related sequence A measurement | 1.92e-03 | 68 | 228 | 4 | EFO_0008233 | |
| Disease | conotruncal heart malformations | 1.96e-03 | 114 | 228 | 5 | MONDO_0016581 | |
| Disease | total cholesterol measurement, low density lipoprotein cholesterol measurement | 1.96e-03 | 114 | 228 | 5 | EFO_0004574, EFO_0004611 | |
| Disease | R-6-hydroxywarfarin measurement | 1.96e-03 | 114 | 228 | 5 | EFO_0803327 | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 2.01e-03 | 291 | 228 | 8 | EFO_0008317, EFO_0020946 | |
| Disease | Uveitis | 2.06e-03 | 9 | 228 | 2 | C0042164 | |
| Disease | N6,N6-dimethyllysine measurement | 2.06e-03 | 9 | 228 | 2 | EFO_0800100 | |
| Disease | Nephritis | 2.06e-03 | 9 | 228 | 2 | C0027697 | |
| Disease | nervonoylcarnitine (C24:1) measurement | 2.06e-03 | 9 | 228 | 2 | EFO_0800549 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TLNSEEDYPNGTWLG | 206 | Q8N9N5 | |
| PVTQVTWHGRGDYLA | 536 | Q14137 | |
| LWVGAGQSLPSSQAY | 466 | Q9BYV9 | |
| QPVGRFFGNSWAETY | 246 | O43488 | |
| SVLVQAGPWVGYEQA | 51 | P43320 | |
| TLNGRTGWFPSNYVR | 201 | Q15052 | |
| GQLYQWEPFTEVQGS | 401 | Q6UY14 | |
| INGNWAVDPPGSYRA | 536 | Q6UY14 | |
| SEYVSARGWQGIDPA | 726 | Q6L9W6 | |
| GQWRPLSVEDIGAYS | 416 | Q9BUH8 | |
| STPWNELNYVGGRGL | 221 | O43823 | |
| TASGGDYWRILNPGE | 936 | Q8IUX7 | |
| PEWSLVEVNGQRGYV | 641 | A1IGU5 | |
| SAPQERLYSTWIGGS | 331 | P42025 | |
| PLHRDGTDGQATVYW | 676 | Q8WXG9 | |
| QAVAGSDYEPVTRQW | 2496 | Q8WXG9 | |
| QGWSPLAEAISYGDR | 176 | Q8N6S4 | |
| GVTWDPLGQYVATLS | 176 | Q13112 | |
| PNGVNEYLTALWSVG | 316 | O75131 | |
| LNGRTGWFPSNYVRE | 226 | Q14155 | |
| EILTGSWSDQTYPEG | 31 | P08603 | |
| WQLNPSGAYGLEQNE | 471 | Q9BWV3 | |
| QGWNNRIEYEPGTGA | 266 | O94985 | |
| PTTGAWRAAYTIING | 391 | P55290 | |
| WRAAYTIINGNPGQS | 396 | P55290 | |
| SPFYNDIILTVGGWN | 681 | Q8IWG1 | |
| SVAPGQQVYSGLWRD | 96 | Q5VUD6 | |
| NYEAGPDAVLGRTIW | 156 | O95861 | |
| ANVLVYEGGSVTWLP | 126 | Q04844 | |
| NSRYQLTLWGPEGNI | 641 | P54802 | |
| RYAGEESLQAWGAPQ | 111 | Q7Z5J4 | |
| NFRRGESIYWGPTAD | 336 | Q8NBR0 | |
| PDNSVVIVTWEYGGL | 316 | Q4ADV7 | |
| SETGALGENYSWQIP | 51 | Q8IXQ6 | |
| GFYPAEITLTWQRDG | 231 | P01893 | |
| VLPDGNGTYQTWVAT | 256 | Q29983 | |
| LGTWTYDGSVVAINP | 166 | P02708 | |
| DTPLHIAARWGYQGV | 566 | Q96NW4 | |
| TTNEEYTGRWERGIQ | 246 | P0C881 | |
| TTNEEYTGRWERGIQ | 246 | B2RC85 | |
| QWYAGINPSDGINSE | 636 | Q8IVT2 | |
| RVVAYNEWGPGESSQ | 501 | P43146 | |
| ATGQWSYAAPLQVGV | 541 | Q9H511 | |
| WEQENHLTLVPGYTG | 276 | Q9H079 | |
| QWVDITDVGPGNYIF | 681 | Q96JB6 | |
| TPEGLTVDWIAGNIY | 1336 | Q9NZR2 | |
| LQENPGTGQWQYSEI | 506 | Q96JK4 | |
| YFRWVPEAQISLGGS | 661 | Q9NXD2 | |
| VWLDGLVSYNAPAGQ | 186 | Q16832 | |
| YAISWVRQAPGQGLE | 51 | P01742 | |
| GPDGYQVSELRTWLE | 276 | P55073 | |
| SYLWEKTQGPDGVQL | 631 | Q8IZA0 | |
| PNGIRIYWQASRGSA | 641 | Q5VTL7 | |
| GPDWNTELYNERSAT | 791 | P46020 | |
| DNGISQWAEGEPRYA | 176 | Q9HB07 | |
| YVVCNTRQNGSWGPE | 71 | O00182 | |
| VRWPDFNQEAYVGGT | 76 | Q10471 | |
| RPGNSIAPSEYWDGQ | 436 | Q6UXY1 | |
| VWGFYDGQQPVLAIT | 71 | P08684 | |
| WPRGFSTQVLLGDVY | 266 | Q9Y5L3 | |
| SGQEVPWLSSVRYGT | 66 | P41279 | |
| WTRNPDAITNEEYGE | 121 | Q58FG0 | |
| GFYPAEITLTWQRDG | 231 | P10321 | |
| EIPQSQGWYTVQSDG | 3366 | Q9Y6V0 | |
| SVGSTTQQGRVPWYS | 321 | Q6UW60 | |
| LQLPFSSWYVDRGGN | 396 | Q9BXM7 | |
| QGYRDADIRSFWPEG | 71 | A6NFU8 | |
| YGTPDNIDIWIGAIA | 606 | P11678 | |
| FGIQAGPEQYSAWVN | 316 | P14222 | |
| YGTPDNIDIWIGAIA | 601 | P22079 | |
| QGSYGWTVTVQELGP | 211 | A8MUP2 | |
| SVGKWQDRYGRAESP | 291 | Q6UN15 | |
| GWNIPYGFNESDLRI | 2666 | Q6ZR08 | |
| YLHWVNERGTVLPQG | 736 | Q14693 | |
| IYHWDLPQTLQDVGG | 1491 | P09848 | |
| RWCQEQTAGYPGVHV | 516 | Q8TDZ2 | |
| GWEALYEQRAEPRSG | 316 | A6NEM1 | |
| GWEALYEQRAEPRSG | 406 | A6NI86 | |
| YVQSQQELLWEGGGR | 901 | P08151 | |
| KQNGTQYRSLWDPTG | 366 | P47870 | |
| QWQPGRALTGNSSVY | 46 | Q969J5 | |
| VLPDGNGTYQTWVAT | 256 | Q29980 | |
| EGYRGTVNTIWNGIP | 311 | P14210 | |
| YDNDVTVWSPQGRIH | 6 | P25786 | |
| VLPNGDGTYQGWITL | 256 | Q30201 | |
| YGAFGVVWSVTDPRD | 146 | Q9UBE8 | |
| GLQVDYWTAAQPADR | 746 | Q86VP3 | |
| LLTIYAWEQGSGVPD | 571 | P29728 | |
| WSPPADNGGRNDVTY | 351 | Q15375 | |
| FTYGEWERENPSGLQ | 306 | Q96KD3 | |
| GFYPAEITLTWQRDG | 231 | P01889 | |
| YAISWVRQAPGQGLE | 51 | A0A0B4J2H0 | |
| NQTGPAWAGSERDYT | 161 | P20042 | |
| FVYSEVQGGAWLLSP | 91 | P21917 | |
| SWIPRGNYIESNRDD | 171 | A8MWY0 | |
| YGISWVRQAPGQGLE | 51 | A0A0C4DH31 | |
| LWPEVYGAERGNLNG | 1816 | P78509 | |
| DHDIVVQYPSGNRWT | 291 | Q86YT6 | |
| TVGDNQTYRGFWNPP | 681 | Q92729 | |
| SGIEWDYIATQGPLQ | 961 | Q16825 | |
| SEAVPVGEASWYING | 4456 | Q5VST9 | |
| VGEASWYINGAAVQP | 4461 | Q5VST9 | |
| WEPGGQLSAQNLYLV | 671 | Q9H158 | |
| QESIESYGAVVWPGA | 81 | Q5VZV1 | |
| SRLNYPENGWTPGED | 306 | O14786 | |
| YTGPNENLLAWVTGA | 596 | Q86VX9 | |
| TGFLAWLYNESPVRG | 241 | Q9BTY2 | |
| VRQYEVTWGIDQFGP | 91 | Q96NE9 | |
| TDPDTGAWGQITYSL | 506 | Q9BYE9 | |
| ILGDPYEIRQWNTDG | 3041 | Q9C0G6 | |
| LSGSVYQECQGTIPW | 501 | P20023 | |
| WTRARRQNGEEGYVP | 576 | Q5T0N5 | |
| RPRNSEGWEQNGLYE | 701 | Q8IWX8 | |
| AQYSGDPRTEWQLNA | 1241 | Q99715 | |
| DTGWSGAYLPSAIEQ | 181 | Q96C92 | |
| SQGVFLARYGPAWRE | 116 | P10635 | |
| WDLGLQEQEGRYTPL | 576 | Q8NHY3 | |
| SWDVPEGNIVIGYSI | 66 | Q9H6D8 | |
| QIPQYLAEAGWTAEG | 86 | Q9H5Z1 | |
| DTVAFVPISGWNGDN | 186 | P68104 | |
| DNNERSKWYVTGPGG | 486 | P15924 | |
| GSLGPWKITIYDQEN | 26 | P05813 | |
| GRQWEISDDYPSLQA | 136 | P05813 | |
| VVYEAPGFQGRSWEV | 1171 | Q8N1P7 | |
| PGFQGRSWEVSRDIY | 1176 | Q8N1P7 | |
| QWIGVPGELRGYAEA | 136 | P36269 | |
| SAPQERLYSTWIGGS | 331 | P61163 | |
| SAGWPDRVTFRGQYT | 1206 | Q7Z591 | |
| TYPDGSQDVGLWFRE | 86 | Q9P2S6 | |
| DYSGQFLQPEAWRRG | 226 | P62955 | |
| YVVSWRPSGQAGAIL | 371 | Q99062 | |
| QAVEGGEVVLPAWYT | 41 | Q96AP7 | |
| GFYPAEITLTWQRDG | 231 | P04439 | |
| QEGDEGLWYVRDPTT | 1086 | O15068 | |
| RWSSQQGNKADYPEG | 111 | Q8WWU7 | |
| DTVAFVPISGWNGDN | 186 | Q5VTE0 | |
| YGQDDWNGTRPSLKA | 411 | Q07666 | |
| NTSNPGYRLIGQWTD | 486 | Q14831 | |
| AGWLRDGSVQYPVNR | 211 | Q86UW8 | |
| WRDPDQTDGLGLSYL | 396 | P06396 | |
| APGTYNWKGTARVEL | 216 | Q13683 | |
| SDDGQKWTVYREPGV | 386 | Q96PD2 | |
| GWNRSYPFNTGDLTI | 4071 | Q9NYC9 | |
| WSPQEEDRIIEGGIY | 21 | P09228 | |
| LARTLNWGGGYTDEP | 386 | Q13574 | |
| AEDTGVDTGAPYWTR | 141 | P22607 | |
| RERETGQGPGSVLYW | 121 | Q9NYQ7 | |
| GQAAWQDGLVPYQER | 126 | Q9BYK8 | |
| TLGWEAYTQPQAEGV | 316 | O95180 | |
| SWQEPLEKNGIITGY | 991 | Q7Z5N4 | |
| FVWIAGRYERASQGP | 556 | Q8IY34 | |
| YTVDGVWTAQRPGIT | 451 | P51172 | |
| IEQGWTYGPVRDDNK | 886 | P21817 | |
| GQGWSYSAVQDIPAR | 1001 | P21817 | |
| ALEPHVYEWTAGQQG | 456 | Q8N465 | |
| SGYSRSSQGQPWRDQ | 881 | Q96EK7 | |
| PWRDQGPGSRQYEHD | 891 | Q96EK7 | |
| TVGDNRTYQGFWNPP | 686 | Q15262 | |
| DYNQWNNLIEGIGPS | 366 | Q99487 | |
| DQYWPSRGTETHGLV | 1466 | P23468 | |
| VDINIYDWNGGTPLL | 181 | O14593 | |
| NAGWLSDGSVQYPIT | 206 | P10915 | |
| WGNQPERLNAGTYFL | 136 | P03905 | |
| WNGDNSAGYLTVPLR | 231 | Q86XP0 | |
| WYTASGPQLNAQLEG | 16 | Q9Y316 | |
| WDSYSPQGRRPETQG | 306 | Q9H239 | |
| GQPSWTIEEYARNAG | 826 | Q9UPX6 | |
| GYRQPLEGSDLWSLN | 231 | P33527 | |
| WRYGQSSPRLQAGDA | 316 | Q8NEY1 | |
| VVRYVGPADFQEGTW | 1716 | Q9NQT8 | |
| RYSDNWEAITGTGDP | 1386 | P11717 | |
| SVDGSLIGNEPVWLY | 461 | A6NKG5 | |
| QGSLWERLAYGITPE | 581 | P23975 | |
| GSQEERFAPGWNRDY | 16 | P78332 | |
| AWLQPTGRETGVQVY | 41 | Q9HA77 | |
| DIPTYNRTGGNSWQV | 286 | Q8NB59 | |
| NRWAVEREGATPYNS | 586 | P31641 | |
| GYPLWSLGREVTTNQ | 401 | Q9BUR4 | |
| WQVEYPGEITSDLGV | 401 | Q14C87 | |
| GTGVWARNPQYRAEG | 61 | Q8NFB2 | |
| YNGLPVLTTNAIGQW | 76 | Q8WUG5 | |
| VLQDSLGRWYSTPSG | 706 | P0DPF3 | |
| SDQLLGPSDLWGYVS | 176 | Q86YW0 | |
| YLQGSGETPQTDVRW | 341 | Q14697 | |
| NGNITWADVEARYPL | 711 | P41250 | |
| RTWDPEGVIFYGDTN | 76 | P04278 | |
| YWNLGFTSVPQGQDL | 211 | Q9UJ37 | |
| YNWSPLGEEGNVLQI | 166 | Q9UIB8 | |
| GVEQWPYRAVAQALE | 431 | P49368 | |
| TWQLQPVEGELYANG | 346 | Q9UKZ4 | |
| VVPGGQVYWLTISSN | 1601 | Q9UKZ4 | |
| QPDRSVTGGAWYSDQ | 156 | Q9H1D9 | |
| EVLIGSGYNTPADIW | 521 | Q96SB4 | |
| AWPTEGGDDLSYTQT | 881 | Q9BZV3 | |
| DAVLYGEQGQPWGRF | 506 | P11215 | |
| VPALWSEVNRYGQNG | 11 | O76094 | |
| RQSQVPDGGSRWATY | 156 | E7EW31 | |
| EGDYIVSVNGQPCRW | 551 | Q8TCX5 | |
| GTPVIYQNWDTGRER | 891 | Q13018 | |
| VDQNWYEGKIPGTNR | 971 | O94875 | |
| EGYITDISTGPSWLN | 346 | Q14188 | |
| NNLYAWGQETGAPIL | 731 | Q15437 | |
| GNQVWLYAGIVAETP | 271 | Q15047 | |
| SYGGWQVLDATPQER | 346 | Q08188 | |
| ISEVWDYNTGRVGAP | 486 | O95573 | |
| PGGINAWNTITSYID | 131 | Q6UW56 | |
| PGVQELYTHWLQGTD | 436 | Q9H6Q4 | |
| QQSGALYIPGWIEND | 691 | A8K7I4 | |
| GSLINLTWTAPGDDY | 766 | A8K7I4 | |
| NRAAYIPGWVVNGEI | 696 | Q14CN2 | |
| AYSPRGNWEVNGKTI | 181 | A5D8T8 | |
| AYSPRGNWEVNGKTI | 181 | Q8NCF0 | |
| TSRGYLVWFEPSQGT | 301 | Q6P3X8 | |
| TPSGYEWGRQNTDKG | 2231 | Q6P2Q9 | |
| PGWEIRNTATGRVYF | 301 | Q9HAU4 | |
| WGAQEYAGHTVPELR | 311 | O60235 | |
| TGKDNLLNAWRTPYG | 716 | Q04724 | |
| YWPLGTNAENEGNRK | 16 | Q9UI72 | |
| QLNGGQYWAVTSPER | 436 | Q9C029 | |
| TEVWTLPQVAGQRYG | 821 | P10745 | |
| VAPGYFSRDGWQLQV | 81 | Q8WVN6 | |
| YLSSQNGQPLWILGD | 351 | P20142 | |
| SGQDGYSGLQPRRWA | 186 | Q8N7X1 | |
| PVTRGQDVGRYQVSW | 76 | P51571 | |
| GWGAEYRRQTVTSTP | 421 | Q15796 | |
| EQGWVPATYLEAQNG | 211 | Q5TCZ1 | |
| TLPWNAGYAEIINAE | 66 | Q96MI6 | |
| DENWYEGRIPGTSRQ | 901 | Q9BX66 | |
| NNDRTYWELLSGGEP | 396 | P20061 | |
| GGRISPQTVWDYVEK | 1246 | Q92576 | |
| SHWEQEISLQGNYPG | 26 | Q9GZW5 | |
| DPSGQWRDTRVYGVF | 311 | O75326 | |
| PDNVGDWLRGVYRFA | 21 | Q96B49 | |
| YVLEGRQGSQGWEVL | 656 | Q9P2J2 | |
| LVGNSWTPGYPETQE | 276 | Q93038 | |
| PVLGWFSQSVDYGLN | 361 | Q7Z3V4 | |
| TPEGSQGEVDWLQQY | 786 | Q86T82 | |
| YSRGTNPSAWVGSVE | 346 | P22735 | |
| NGRIGWFPSTYVEEE | 861 | P52735 | |
| WYGNNTEPLITLEGS | 926 | Q8WY21 | |
| VFSSLQWYRQEPGEG | 46 | A0A087WT01 | |
| TEPQLSGVGDRQWLY | 361 | Q9NQE7 | |
| ARQDLGPSYNGWQVL | 341 | O95932 | |
| DWPAGLTTYRSIQVG | 21 | Q8NHX9 | |
| ASGQRADGYPIWSRQ | 351 | Q9NYB0 | |
| VNGRVGWFPSTYVEE | 831 | Q9UKW4 | |
| NLTWPNGLAIDYGSQ | 901 | O75096 | |
| DISFTWRYQPEGGRD | 61 | P25189 | |
| WRYQPEGGRDAISIF | 66 | P25189 | |
| LIDIYSASWGPTDNG | 261 | P16519 |